STOCK TITAN

Hawkeye Digital posts $681K in first quarterly revenue

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Hawkeye Digital, Inc. (HWKE) reported $681,290 in advisory revenue for the quarter ended September 30, 2026, its first revenue, all from one Omnitek engagement; $300,000 was cash and $381,290 was Omnitek warrants measured at fair value. Omnitek instruments produced a $1,614,095 unrealized gain; net loss was $(146,911), versus $(101,533) a year earlier, while operating loss was $(1,771,773). The instruments’ $2,545,385 fair value uses Level 3 inputs and depends on Omnitek’s thinly traded stock price.

Cash fell to $1,190,461 from $2,105,343 at June 30, 2026, and operating activities used $354,882. The Omnitek securities are restricted and not readily convertible into cash. Management’s existing-cash projection excludes potential acquisition costs and salaries; the four employees deferred their $900,000 aggregate annual salaries until the later of January 1, 2027 and additional fundraising. On its projection, management concluded that conditions did not raise substantial doubt about continued operations, but said additional capital is needed for its strategy and potential acquisition. Disclosure controls were ineffective as of September 30, 2026, with material weaknesses unremediated.

1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 3 points

How the balance works

Positive

  • Moderate pointAdjusted EBITDA (non-GAAP) was $320,102, versus $(33,507) a year earlier.

Negative

  • Major pointDisclosure controls were ineffective as of September 30, 2026, with material weaknesses unremediated.
  • Moderate pointOperating cash used was $354,882, compared with $59,611 a year earlier.
  • Minor pointNet loss was $(146,911), compared with $(101,533) in the prior-year quarter.

Filing Explained

The completed cashless exercise diluted existing holders’ percentage ownership and brought no cash into Hawkeye.

In October 2026, all 14,000,000 advisory warrants were exercised cashlessly; Hawkeye issued 13,718,436 common shares on October 13 and 14, received no cash, and has no warrants remaining. The completed issuance increased the share count, reducing existing holders’ percentage ownership absent offsetting changes.

Hawkeye also entered a tokenization agreement with Securitize on November 2, 2026; tokens will represent existing common shares, not create a new class. The agreement calls for a $75,000 setup fee payable upon execution, plus issuance, monthly servicing, and other fees, which are expensed as services are received.

Advisory revenue $681,290 Three months ended September 30, 2026; included $300,000 cash and $381,290 in noncash warrant consideration.
Net loss $(146,911) Three months ended September 30, 2026; compared with $(101,533) in the prior-year quarter.
Unrealized gain on investments $1,614,095 Gain on Omnitek warrants and option for the three months ended September 30, 2026.
Investments at fair value $2,545,385 Omnitek warrants and option as of September 30, 2026; classified within Level 3.
Cash $1,190,461 As of September 30, 2026, compared with $2,105,343 as of June 30, 2026.
Net cash used in operating activities $(354,882) Three months ended September 30, 2026; compared with $(59,611) in the prior-year quarter.
Adjusted EBITDA (non-GAAP) $320,102 Three months ended September 30, 2026; compared with $(33,507) in the prior-year quarter.
noncash consideration financial
"Noncash consideration, including warrants and options to acquire a customer’s equity securities"
Level 3 financial
"the measurements are categorized within Level 3"
Level 3 describes the lowest-confidence category in the accounting “fair value” hierarchy, covering assets or liabilities whose prices are not observable in the market and must be estimated using judgment and internal models. For investors, Level 3 items matter because they can introduce greater uncertainty and potential valuation swings—like valuing a unique antique versus checking a price tag on a supermarket shelf—so they signal higher model risk and lower liquidity.
Black-Scholes option-pricing model financial
"using the Black-Scholes option-pricing model"
Rule 144 holding period regulatory
"may not be resold until the Rule 144 holding period has elapsed"
cashless basis financial
"exercised all 14,000,000 warrants in full on a cashless basis"
An agreement executed on a cashless basis lets a holder convert or exercise a security (like options, warrants, or conversion rights) without paying money upfront; instead the holder receives a smaller number of shares equal in value to what the cash would have purchased. Think of trading a coupon for fewer slices of a cake rather than handing over cash for the full slice. For investors, it affects how much ownership and dilution occur and avoids immediate cash outlays.
material weakness technical
"A material weakness is a deficiency, or combination of deficiencies, in internal control"
A material weakness is a significant flaw in the systems and checks a company uses to ensure its financial reports are accurate, meaning errors or fraud could happen and not be caught. For investors it matters because it raises the risk that reported results are unreliable—similar to finding a hole in a ship’s hull—potentially leading to corrected financials, regulatory action, reduced trust, and negative effects on stock value and borrowing costs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much revenue and net loss did HWKE report for the September 2026 quarter?

Hawkeye reported $681,290 of advisory revenue and a net loss of $(146,911) for the three months ended September 30, 2026. Revenue came from one Omnitek engagement and included $300,000 in cash and $381,290 in warrants.

How much cash and working capital did HWKE have at September 30, 2026?

Cash was $1,190,461, and working capital was $3,642,359. Excluding $2,545,385 of Omnitek investments and $150,000 of deferred offering costs, working capital was $946,974.

Why did HWKE say its disclosure controls were ineffective?

Disclosure controls were not effective as of September 30, 2026. Hawkeye cited five unremediated weaknesses: two officers handling financial transactions, inadequate operational controls and accounting information, incomplete daily financial statements and accounting-system errors, deficient documentation, and limited segregation of duties.

When do HWKE's $900,000 annual salaries begin?

The four employees agreed on November 15, 2026, to defer compensation until the later of January 1, 2027 and completion of additional fundraising. Their offer letters provide for aggregate annual salaries of $900,000; no compensation was earned or accrued as of September 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false --06-30 2027 Q1 0001750777 1 1 0001750777 2026-07-01 2026-09-30 0001750777 2026-11-12 0001750777 2026-09-30 0001750777 2026-06-30 0001750777 2025-07-01 2025-09-30 0001750777 hwke:StockBasedCompenasationMember 2026-07-01 2026-09-30 0001750777 hwke:StockBasedCompenasationMember 2025-07-01 2025-09-30 0001750777 us-gaap:CommonStockMember 2026-06-30 0001750777 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001750777 hwke:StockToBeIssuedMember 2026-06-30 0001750777 us-gaap:RetainedEarningsMember 2026-06-30 0001750777 us-gaap:CommonStockMember 2025-06-30 0001750777 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001750777 hwke:StockToBeIssuedMember 2025-06-30 0001750777 us-gaap:RetainedEarningsMember 2025-06-30 0001750777 2025-06-30 0001750777 us-gaap:CommonStockMember 2026-07-01 2026-09-30 0001750777 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0001750777 hwke:StockToBeIssuedMember 2026-07-01 2026-09-30 0001750777 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0001750777 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001750777 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001750777 hwke:StockToBeIssuedMember 2025-07-01 2025-09-30 0001750777 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001750777 us-gaap:CommonStockMember 2026-09-30 0001750777 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0001750777 hwke:StockToBeIssuedMember 2026-09-30 0001750777 us-gaap:RetainedEarningsMember 2026-09-30 0001750777 us-gaap:CommonStockMember 2025-09-30 0001750777 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001750777 hwke:StockToBeIssuedMember 2025-09-30 0001750777 us-gaap:RetainedEarningsMember 2025-09-30 0001750777 2025-09-30 0001750777 us-gaap:CommonStockMember 2026-08-19 0001750777 us-gaap:CommonStockMember 2026-08-20 0001750777 hwke:RiftCyberMember 2026-09-30 0001750777 hwke:RedChipCompaniesInc.Member 2026-09-30 0001750777 hwke:OmnitekInvestmentsMember 2026-09-30 0001750777 hwke:BusinessAcquisitionValueMember 2026-09-30 0001750777 hwke:OmnitekWarrantsMember 2026-07-01 2026-09-30 0001750777 hwke:FourEmployessMember hwke:AtWillOfferLettersMember 2026-09-30 0001750777 hwke:OmnitekMember 2026-07-01 2026-09-30 0001750777 hwke:OmnitekMember hwke:OmnitekWarrantsMember 2026-09-30 0001750777 hwke:CashConsiderationMember 2026-07-01 2026-09-30 0001750777 hwke:OmnitekFeeWarrantsMember 2026-09-30 0001750777 hwke:OmnitekFeeWarrantsMember 2026-07-01 2026-09-30 0001750777 hwke:OmnitekWarrant202601Member 2026-09-30 0001750777 hwke:OmnitekWarrant202601Member 2026-06-30 0001750777 hwke:OmnitekWarrant202601Member 2026-07-01 2026-09-30 0001750777 hwke:OmnitekWarrant202602Member 2026-09-30 0001750777 hwke:OmnitekWarrant202602Member 2026-06-30 0001750777 hwke:OmnitekWarrant202602Member 2026-07-01 2026-09-30 0001750777 hwke:OmnitekOptionMember 2026-09-30 0001750777 hwke:OmnitekOptionMember 2026-06-30 0001750777 hwke:OmnitekOptionMember 2026-07-01 2026-09-30 0001750777 hwke:OmnitekInstrumentsMember 2026-06-30 0001750777 hwke:OmnitekInstrumentsMember 2026-07-01 2026-09-30 0001750777 hwke:OmnitekInstrumentsMember 2026-09-30 0001750777 hwke:Warrant202601PurchasePriceMember 2026-06-30 0001750777 hwke:FairValueOption202601OverPurchasePriceMember 2026-06-30 0001750777 hwke:FairValueWarrant202601OverPurchasePriceMember 2026-06-30 0001750777 hwke:OmnitekFeeWarrantsMember 2026-01-01 2026-09-30 0001750777 hwke:FairValueOption202601OverPurchasePriceMember 2026-07-01 2026-09-30 0001750777 hwke:ChangeInFairValueMember 2026-07-01 2026-09-30 0001750777 us-gaap:FairValueMeasurementsRecurringMember 2026-06-30 0001750777 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember hwke:OmnitekWarrantsAndOptionMember 2026-09-30 0001750777 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember hwke:OmnitekWarrantsAndOptionMember 2026-09-30 0001750777 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember hwke:OmnitekWarrantsAndOptionMember 2026-09-30 0001750777 us-gaap:FairValueMeasurementsRecurringMember hwke:OmnitekWarrantsAndOptionMember 2026-09-30 0001750777 us-gaap:FairValueInputsLevel3Member 2026-06-30 0001750777 us-gaap:FairValueInputsLevel3Member 2026-07-01 2026-09-30 0001750777 us-gaap:FairValueInputsLevel3Member 2026-09-30 0001750777 us-gaap:MeasurementInputPriceVolatilityMember 2026-09-28 2026-09-30 0001750777 us-gaap:MeasurementInputPriceVolatilityMember 2026-09-28 2026-09-29 0001750777 us-gaap:MeasurementInputPriceVolatilityMember hwke:OmnitekWarrantsMember 2026-09-28 2026-09-30 0001750777 us-gaap:MeasurementInputPriceVolatilityMember hwke:OmnitekWarrantsMember 2026-09-28 2026-09-29 0001750777 us-gaap:MeasurementInputPriceVolatilityMember hwke:OmnitekOptionMember 2026-09-28 2026-09-30 0001750777 us-gaap:MeasurementInputPriceVolatilityMember hwke:OmnitekOptionMember 2026-09-28 2026-09-29 0001750777 hwke:MeasurementInputResaleDateMember hwke:OmnitekWarrantsMember 2026-09-28 2026-09-30 0001750777 hwke:MeasurementInputResaleDateMember hwke:OmnitekWarrantsMember 2026-09-28 2026-09-29 0001750777 hwke:MeasurementInputResaleDateMember hwke:OmnitekOptionMember 2026-09-28 2026-09-30 0001750777 hwke:MeasurementInputResaleDateMember hwke:OmnitekOptionMember 2026-09-28 2026-09-29 0001750777 us-gaap:MeasurementInputExpectedTermMember hwke:OmnitekWarrantsMember 2026-09-28 2026-09-30 0001750777 us-gaap:MeasurementInputExpectedTermMember hwke:OmnitekWarrantsMember 2026-09-28 2026-09-29 0001750777 us-gaap:MeasurementInputExpectedTermMember hwke:OmnitekOptionMember 2026-09-28 2026-09-30 0001750777 us-gaap:MeasurementInputExpectedTermMember hwke:OmnitekOptionMember 2026-09-28 2026-09-29 0001750777 us-gaap:MeasurementInputRiskFreeInterestRateMember hwke:OmnitekWarrantsMember 2026-09-28 2026-09-30 0001750777 us-gaap:MeasurementInputRiskFreeInterestRateMember hwke:OmnitekWarrantsMember 2026-09-28 2026-09-29 0001750777 us-gaap:MeasurementInputRiskFreeInterestRateMember hwke:OmnitekOptionMember 2026-09-28 2026-09-30 0001750777 us-gaap:MeasurementInputRiskFreeInterestRateMember hwke:OmnitekOptionMember 2026-09-28 2026-09-29 0001750777 us-gaap:DirectorsAndOfficersLiabilityInsuranceMember 2026-09-30 0001750777 us-gaap:DirectorsAndOfficersLiabilityInsuranceMember 2026-06-30 0001750777 hwke:LegalRetainersMember 2026-09-30 0001750777 hwke:LegalRetainersMember 2026-06-30 0001750777 hwke:OTCMarketFeesMember 2026-09-30 0001750777 hwke:OTCMarketFeesMember 2026-06-30 0001750777 hwke:AdvisoryAgreementMember hwke:ThinkEquityMember hwke:HawkeyeWarrantsMember 2026-07-19 2026-07-20 0001750777 hwke:AdvisoryAgreementMember hwke:ThinkEquityMember 2026-07-19 2026-07-20 0001750777 hwke:AdvisoryAgreementMember hwke:AdvisorMember 2026-09-30 0001750777 hwke:PrivatePlacementAgreementMember hwke:AdvisorMember 2026-07-19 2026-07-20 0001750777 srt:PresidentMember 2026-08-29 2026-09-01 0001750777 srt:ChiefFinancialOfficerMember 2026-08-29 2026-09-01 0001750777 srt:VicePresidentMember 2026-08-29 2026-09-01 0001750777 hwke:HawkeyeHoldcoMember hwke:WachsmanAndHamlettMember 2026-09-30 0001750777 hwke:HawkeyeHoldcoMember hwke:WachsmanAndHamlettMember 2026-11-03 0001750777 us-gaap:PreferredStockMember 2026-08-20 0001750777 hwke:CheckmateGovernmentRelationsMember 2026-09-30 0001750777 hwke:RedchipCompaniesMember 2026-09-30 0001750777 us-gaap:SubsequentEventMember 2026-11-03 0001750777 us-gaap:SubsequentEventMember hwke:October2026CashlessExerciseOfAdvisoryWarrantsMember 2026-11-03 0001750777 hwke:EquityIncentivePlan2026Member 2026-07-01 2026-09-30 0001750777 hwke:WarrantsIssuedToAdvisorMember 2026-07-01 2026-09-30 0001750777 hwke:InvestorRelationsConsultantMember 2026-07-01 2026-09-30 0001750777 hwke:RedchipCompaniesMember us-gaap:RestrictedStockMember 2026-07-13 2026-07-14 0001750777 hwke:RedchipCompaniesMember us-gaap:RestrictedStockMember 2026-09-30 0001750777 us-gaap:WarrantMember 2026-06-30 0001750777 us-gaap:WarrantMember 2026-07-01 2026-09-30 0001750777 us-gaap:WarrantMember 2026-09-30 0001750777 hwke:TransactionCostsMember hwke:PotentialBusinessAcquisitionMember 2026-07-01 2026-09-30 0001750777 hwke:TransactionCostsMember hwke:PotentialBusinessAcquisitionMember us-gaap:AcquisitionRelatedCostsMember 2026-07-01 2026-09-30 0001750777 us-gaap:EmployeeStockOptionMember 2026-07-01 2026-09-30 0001750777 us-gaap:EmployeeStockOptionMember 2025-07-01 2025-09-30 0001750777 hwke:SharesToBeIssuedMember 2026-07-01 2026-09-30 0001750777 hwke:SharesToBeIssuedMember 2025-07-01 2025-09-30 0001750777 us-gaap:CorporateAndOtherMember 2026-07-01 2026-09-30 0001750777 us-gaap:CorporateAndOtherMember 2025-07-01 2025-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure hwke:Integer

Table of Contents

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2026

 

OR

 

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ____________ to ____________

 

Commission File Number: 000-56332

 

HAWKEYE DIGITAL, INC.
(Exact Name of Registrant as Specified in Its Charter)

 

Nevada 83-0799093
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification Number)

 

350 Lincoln Road, 2nd Floor, Miami Beach, Florida 33139
(Address of principal executive offices) (Zip Code)

 

(800) 576-4953

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
None N/A N/A

 

Securities registered pursuant to Section 12(g) of the Exchange Act: Common Stock, $0.0001 par value per share (OTC: HWKE)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
    Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Yes ☐ No ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

The number of shares outstanding of each of the issuer’s classes of common equity as of November 12, 2026, were 279,771,362 shares of common stock.

 

   

TABLE OF CONTENTS

 

    Page
     
PART I. FINANCIAL INFORMATION 3
Item 1. Financial Statements 3
  Condensed Balance Sheets as of September 30, 2026 (Unaudited) and June 30, 2026 (audited) 3
  Condensed Statements of Operations for the Three Months Ended September 30, 2026 and 2025 (Unaudited) 4
  Condensed Statements of Changes in Stockholders’ Equity (Deficit) for the Three Months Ended September 30, 2026 and 2025 (Unaudited) 5
  Condensed Statements of Cash Flows for the Three Months Ended September 30, 2026 and 2025 (Unaudited) 6
  Notes to the Condensed Financial Statements (Unaudited) 7
  Special Note Regarding Forward-Looking Statements 20
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 21
Item 3. Quantitative and Qualitative Disclosures About Market Risk 31
Item 4. Controls and Procedures 31
     
PART II. OTHER INFORMATION 33
Item 1. Legal Proceedings 33
Item 1A. Risk Factors 33
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 36
Item 3. Defaults Upon Senior Securities 36
Item 4. Mine Safety Disclosures 36
Item 5. Other Information 36
Item 6. Exhibits 37
  Signatures 38

 

 

 

 2 

 

PART I—FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

HAWKEYE DIGITAL, INC.

Condensed Balance Sheets

 

               
  

(Unaudited)

September 30,
2026

 

(Audited)

June 30, 2026

ASSETS          
Current assets:          
Cash  $1,190,461   $2,105,343 
Prepaid expenses (Note 7)   118,770    119,027 
Deferred offering costs (Note 8)   150,000    – 
Investments, at fair value (Note 5)   2,545,385    – 
Total current assets   4,004,616    2,224,370 
           
Equity method investment – Rift Cyber LLC (Note 6)   39,800    39,800 
Total assets  $4,044,416   $2,264,170 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current liabilities:          
Accounts payable and accrued liabilities (Note 9)  $362,257   $272,782 
Total current liabilities   362,257    272,782 
           
Commitments and contingencies (Note 13)   –      
           
Stockholders’ equity:          
Preferred stock, $0.0001 par value; 50,000,000 shares authorized; none issued and outstanding   –    – 
Common stock, $0.0001 par value; 10,000,000,000 and 400,000,000 shares authorized as of September 30, 2026 and June 30, 2026, respectively; 266,052,926 shares issued and outstanding as of each date   26,605    26,605 
Additional paid-in capital   17,406,291    15,604,207 
Stock to be issued (450,000 and 200,000 shares as of September 30, 2026 and June 30, 2026, respectively)   179,598    144,000 
Accumulated deficit   (13,930,335)   (13,783,424)
Total stockholders’ equity   3,682,159    1,991,388 
Total liabilities and stockholders’ equity  $4,044,416   $2,264,170 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 

 

 3 

 

HAWKEYE DIGITAL, INC.

Condensed Statements of Operations

(Unaudited)

           
   Three Months Ended September 30,
   2026  2025
Revenue (Note 4)  $681,290   $– 
           
Operating expenses:          
Professional fees (1)   1,899,912    27,127 
Acquisition-related costs   394,193    – 
Sales and marketing (1)   58,153    – 
General and administrative   100,805    6,380 
Total operating expenses   2,453,063    33,507 
           
Loss from operations   (1,771,773)   (33,507)
           
Other income (expense), net:          
Interest income   11,283    – 
Interest expense   (516)   – 
Interest expense – related party   –    (68,026)
Unrealized gain on investments (Note 5)   1,614,095    – 
Total other income (expense), net   1,624,862    (68,026)
           
Loss before provision for income taxes   (146,911)   (101,533)
           
Provision for income taxes (Note 12)   –    – 
Net loss  $(146,911)  $(101,533)
           
Net loss per common share – basic and diluted (Note 14)  $(0.00)  $(0.01)
Weighted-average common shares outstanding – basic   277,576,296    8,706,772 
Weighted-average common shares outstanding – diluted   277,576,296    8,706,772 

 

(1)    Includes stock-based compensation as follows:                
Professional fees   $ 1,662,084     $ –  
Sales and marketing     35,598       –  

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 

 

 4 

 

HAWKEYE DIGITAL, INC.

Condensed Statements of Changes in Stockholders’ Equity (Deficit)

(Unaudited)

 

Three Months Ended September 30, 2026

                               
   Common Shares  Common Stock Amount 

Additional

Paid-in Capital

  Stock to be Issued  Accumulated Deficit  Total Equity
Balance, June 30, 2026   266,052,926   $26,605   $15,604,207   $144,000   $(13,783,424)  $1,991,388 
Advisory warrants issued for cash and services (Note 8)   –    –    1,802,084    –    –    1,802,084 
Common stock to be issued for investor relations consulting services (Note 11)   –    –    –    35,598    –    35,598 
Net loss   –    –    –    –    (146,911)   (146,911)
Balance, September 30, 2026   266,052,926   $26,605   $17,406,291   $179,598   $(13,930,335)  $3,682,159 

 

 

Three Months Ended September 30, 2025

 

   Common Shares  Common Stock Amount 

Additional

Paid-in Capital

  Stock to be Issued  Accumulated Deficit  Total Equity (Deficit)
Balance, June 30, 2025   8,706,772   $870   $10,082,307   $50,000   $(13,210,531)  $(3,077,354)
Reclassification of accounts payable – related party to stock to be issued   –    –    –    110,000    –    110,000 
Net loss   –    –    –    –    (101,533)   (101,533)
Balance, September 30, 2025   8,706,772   $870   $10,082,307   $160,000   $(13,312,064)  $(3,068,887)

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 

 

 5 

 

HAWKEYE DIGITAL, INC.

Condensed Statements of Cash Flows

(Unaudited)

           
   Three Months Ended September 30,
   2026  2025
Cash flows from operating activities:          
Net loss  $(146,911)  $(101,533)
Adjustments to reconcile net loss to net cash used in operating activities:          
Unrealized gain on investments   (1,614,095)   – 
Share-based compensation – investor relations consultant shares (Note 11)   35,598    – 
Share-based payments – advisory warrants (Note 8)   1,662,084    – 
Noncash consideration received for advisory services   (381,290)   – 
Changes in operating assets and liabilities:          
Prepaid expenses   257    (12,085)
Accounts payable and accrued liabilities   89,475    (14,018)
Accrued interest – related party   –    68,025 
Net cash used in operating activities   (354,882)   (59,611)
           
Cash flows from investing activities:          
Purchase of investments – Omnitek warrants   (550,000)   – 
Investment in equity method investee – Rift Cyber LLC   –    (10,000)
Net cash used in investing activities   (550,000)   (10,000)
           
Cash flows from financing activities:          
Proceeds from sale of common stock purchase warrants   140,000    – 
Payment of deferred offering costs (Note 8)   (150,000)   – 
Proceeds from related-party promissory note   –    69,427 
Net cash provided by (used in) financing activities   (10,000)   69,427 
           
Net change in cash   (914,882)   (184)
Cash, beginning of period   2,105,343    502 
Cash, end of period  $1,190,461   $318 
           
Supplemental cash flow information:          
Cash paid for interest  $516   $– 
Cash paid for income taxes  $–   $– 
           
Noncash investing and financing activities:          
Omnitek warrants received as noncash consideration for advisory services  $381,290   $– 
Omnitek option received in the Omnitek transaction  $62,058   $– 
Reclassification of accounts payable – related party to stock to be issued  $–   $110,000 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 

 

 6 

 

HAWKEYE DIGITAL, INC.

Notes to the Condensed Financial Statements

(Unaudited)

 

Note 1 - Description of business

 

Organization and nature of business

 

Hawkeye Digital, Inc. (the “Company”), formerly Hawkeye Systems, Inc., is a Nevada corporation incorporated on May 15, 2018. On August 20, 2026, the Company’s Amended and Restated Articles of Incorporation, which had been approved by the holders of a majority of the voting power of the Company’s common stock on June 17, 2026, became effective. Among other things, they changed the Company’s name to Hawkeye Digital, Inc. and increased authorized common stock from 400,000,000 to 10,000,000,000 shares (Note 11, Stockholders’ equity).

 

Following the change in control described below, the Company operates as a private equity and corporate advisory firm conducting merchant banking services in digital assets and other frontier verticals in financial services and technology. The Company earned its first advisory fee revenue during the three months ended September 30, 2026 (Note 4, Revenue). As of September 30, 2026, the Company had not acquired a registered broker-dealer, registered investment adviser or other operating business.

 

The Company holds a 19.9% membership interest in Rift Cyber LLC (“Rift”), a Nevada limited liability company holding intellectual property relative to certain physical security and cybersecurity. Rift has not generated revenue since formation (Note 6, Equity method investment).

 

During the quarter, the Company incurred costs in pursuit of a potential business acquisition pursuant to a non-binding letter of intent. See Note 3, Liquidity.

 

Change in control

 

Effective April 1, 2026, the Company underwent a change in control as a result of a series of related transactions with Hawkeye Holdco LLC, a Wyoming limited liability company (“HH”), and Steve Hall, which were completed in June 2026 and are described in Note 1, Description of business, of the 2026 Form 10-K. As a result of those transactions, HH beneficially owned approximately 91% of the Company’s outstanding common stock as of September 30, 2026 and June 30, 2026, and HH has the right under an Investor Rights Agreement to designate four of the five members of the Board of Directors. Martin Sumichrast, Chairman of the Board, is the manager of MCIMAC, LLC, which is the manager of HH, and David Wachsman, President, and Q. Byron Hamlett, Chief Financial Officer, hold minority membership interests in HH (Note 10, Related party transactions). The change in control resulted in an ownership change under Section 382 of the Internal Revenue Code (Note 12, Income taxes).

 

Principal office

 

The Company’s principal executive offices are located at 350 Lincoln Road, 2nd Floor, Miami Beach, Florida 33139, under a month-to-month mail-and-meeting arrangement. See Note 13, Commitments and contingencies.

 

Note 2 – Summary of significant accounting policies

 

Basis of presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to those rules and regulations. In the opinion of management, the accompanying condensed financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the Company’s financial position as of September 30, 2026 and its results of operations and cash flows for the three months ended September 30, 2026 and 2025. The condensed balance sheet as of June 30, 2026 has been derived from the audited financial statements as of that date. These condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2026, filed with the SEC on September 11, 2026 (the “2026 Form 10-K”). The results of operations for the three months ended September 30, 2026 are not necessarily indicative of the results to be expected for the year ending June 30, 2027 or any other period.

 

The Company has no subsidiaries. Its 19.9% membership interest in Rift Cyber LLC (“Rift”) is accounted for under the equity method.

 

 

 

 7 

 

Use of estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses and related disclosures. The estimates that are most significant to these condensed financial statements are the fair value of the Omnitek warrants and option received as consideration and held as investments (Note 4, Revenue, and Note 5, Investments and fair value measurements); the grant-date fair value of the advisory warrants (Note 8, Advisory warrants and deferred offering costs) and of the 250,000 shares of common stock to be issued to investor relations consultant (Note 11, Stockholders’ equity); the carrying amount of the equity method investment in Rift (Note 6, Equity method investment); and the estimated annual effective tax rate and the valuation allowance on deferred tax assets (Note 12, Income taxes). Actual results could differ from those estimates.

 

Reclassifications

 

Certain prior-period amounts have been reclassified to conform to the current-period presentation, including the presentation of “Selling, general and administrative” expense previously reported for the three months ended September 30, 2025 as “General and administrative,” consistent with the captions used in the 2026 Form 10-K. The reclassifications had no effect on previously reported net loss, total assets, total liabilities or stockholders’ deficit.

 

Significant accounting policies

 

The Company’s significant accounting policies are described in Note 2, Summary of significant accounting policies, of the 2026 Form 10-K. Except as described below, there have been no material changes to those policies during the three months ended September 30, 2026. The following policies became significant during the quarter as a result of new transactions.

 

Revenue recognition

 

The Company recognizes revenue under ASC 606, Revenue from Contracts with Customers, when it transfers control of promised advisory services to a customer, in the amount of consideration to which it expects to be entitled. Noncash consideration, including warrants and options to acquire a customer’s equity securities, is measured at its estimated fair value at contract inception. Changes in the fair value of noncash consideration after contract inception that result from the form of the consideration are not included in the transaction price and are recognized in other income (expense). The Company evaluates each advisory engagement to identify the contract and the promised services. An engagement generally contains a single performance obligation, because the advisory services are highly interrelated and are not distinct within the context of the contract. The transaction price consists of fixed cash fees and noncash consideration. Fees that are contingent on the outcome of a client transaction are variable consideration and are included in the transaction price only to the extent that it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty is resolved. The Company evaluates the criteria in ASC 606-10-25-27 to determine whether each performance obligation is satisfied over time or at a point in time. For the Omnitek engagement, those criteria were not met, and the performance obligation was satisfied at a point in time, on September 29, 2026, when the services were completed and the Company obtained a present right to payment (Note 4, Revenue).

 

Investments, at fair value

 

Warrants and options to acquire equity securities of other entities are measured at fair value, with changes in fair value recognized in earnings as unrealized gain (loss) on investments. The Omnitek warrants (Warrant 2026-01 and Warrant 2026-02, Note 5, Investments and fair value measurements) are derivative instruments under ASC 815, Derivatives and Hedging. The Omnitek option, which requires physical settlement, is accounted for as an equity security under ASC 321, Investments—Equity Securities, and is measured at fair value; the Company has not elected the measurement alternative. Investments are classified as current assets because the Company intends to exercise the Omnitek warrants and option within twelve months.

 

 

 

 8 

 

Deferred offering costs

 

Specific incremental costs directly attributable to a proposed offering of the Company’s securities are deferred and charged against the gross proceeds of the offering when it is completed. If an offering is abandoned or postponed for more than 90 days, the deferred costs are expensed.

 

Concentrations

 

All advisory fee revenue for the three months ended September 30, 2026 was earned from one customer, Omnitek Engineering Corp. (“Omnitek”), and all investments measured at fair value consist of Omnitek instruments. The value of those investments depends on the market price of Omnitek’s thinly traded common stock.

 

Fair value measurements

 

The Company applies ASC 820, Fair Value Measurement, which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 establishes a hierarchy that prioritizes the inputs to valuation techniques:

 

·Level 1 – unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date;
   
·Level 2 – quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, and other inputs that are observable, directly or indirectly; and
   
·Level 3 – unobservable inputs that are significant to the measurement and reflect the assumptions market participants would use in pricing the asset or liability.

 

An asset or liability is categorized in its entirety based on the lowest level input that is significant to the measurement. The Company evaluates the volume and level of activity in the market for an instrument at each measurement date and does not apply a blockage factor. The Company recognizes transfers between levels as of the beginning of the reporting period in which the transfer occurs. The Company has not elected the fair value option under ASC 825 for any eligible financial asset or financial liability. See Note 5, Investments and fair value measurements, for the Company’s recurring fair value measurements.

 

Recently issued accounting pronouncements

 

Recently adopted

 

ASU 2024-04, Debt—Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments, became effective for the Company on July 1, 2026. Adoption had no effect on these condensed financial statements because the Company had no convertible debt instruments outstanding during the period.

 

Not yet adopted

 

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, as clarified by ASU 2025-01. The ASU requires disaggregated disclosure in the notes of specified categories of expense, including employee compensation, included in each relevant expense caption on the face of the statement of operations. It is effective for the Company’s annual period beginning July 1, 2027 and interim periods beginning July 1, 2028, with early adoption permitted.

 

 

 

 9 

 

In September 2025, the FASB issued ASU 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software, which removes references to software development project stages and requires capitalization of internal-use software costs to begin when management has authorized and committed to funding the project and it is probable that the project will be completed and the software used as intended. The ASU is effective for the Company beginning July 1, 2028, with early adoption permitted, and may be applied prospectively, retrospectively or under a modified transition approach.

 

In September 2025, the FASB issued ASU 2025-07, Derivatives and Hedging (Topic 815) and Revenue from Contracts with Customers (Topic 606): Derivatives Scope Refinements and Scope Clarification for Share-Based Noncash Consideration from a Customer in a Revenue Contract. The ASU clarifies that share-based noncash consideration from a customer in a revenue contract, such as the warrants and option the Company received from Omnitek, is accounted for under ASC 606 until the Company’s right to receive or retain the consideration becomes unconditional, and under other applicable guidance thereafter. It is effective for the Company beginning July 1, 2027, with early adoption permitted.

 

In December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements, which clarifies the form and content of interim financial statements and adds a principle requiring disclosure of events and changes since the end of the last annual reporting period that have a material effect on the entity. It is effective for the Company for interim periods beginning July 1, 2028, with early adoption permitted.

 

The Company is evaluating the effect of these ASUs on its financial statements and disclosures. Other recently issued accounting pronouncements are not expected to have a material effect on the Company’s financial statements.

 

Note 3 - Liquidity

 

As of September 30, 2026, the Company had cash of $1,190,461, working capital of $3,642,359 ($946,974 excluding $2,545,385 of investments in Omnitek warrants and option, which are restricted and not readily convertible into cash, and $150,000 of deferred offering costs), no outstanding indebtedness and total liabilities of $362,257, including $231,542 of costs incurred in connection with a potential business acquisition. Cash decreased $914,882 during the quarter. Approximately 77% of that decrease related to investing, financing, transaction-related and other items that management does not expect to recur, principally the $550,000 purchase of Omnitek warrants, the $150,000 non-refundable engagement fee paid to the placement agent for the proposed private placement (Note 8, Advisory warrants and deferred offering costs), the settlement of liabilities outstanding as of June 30, 2026 and costs of the potential acquisition, partially offset by $300,000 of cash advisory fees and $140,000 of proceeds from the sale of warrants.

 

Under at-will offer letters effective September 1, 2026 with four employees, salaries at an aggregate annual rate of $900,000, together with related payroll taxes and Company-paid medical coverage, begin on the later of January 1, 2027 and the Company’s completion of additional fundraising, under the employees’ November 15, 2026 agreement to defer the start of their compensation (Note 16, Subsequent events). No compensation was earned or accrued as of September 30, 2026.

 

Management evaluated whether conditions and events, considered in the aggregate, raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date these condensed financial statements are issued. In making that evaluation, management considered the Company’s history of recurring losses from operations, its accumulated deficit of $13,930,335, its negative cash flows from operating activities, the fact that its only revenue to date was earned from a single advisory engagement and was received in significant part in securities that are not readily convertible into cash, and the compensation that will begin if additional capital is raised. Management also considered that the Company has no indebtedness, financial covenants or capital commitments.

 

The evaluation is based on a cash flow projection through the end of that one-year period that relies only on the Company’s existing cash. The projection reflects the Company’s recurring costs of maintaining its corporate existence and public reporting, estimated at $105,000 per quarter; ongoing discretionary spending of approximately $47,000 per quarter; payment of accounts payable outstanding as of September 30, 2026 other than costs of the potential acquisition; the cost of filing the Company’s delinquent income tax returns; and the fees payable under the tokenization agreement the Company entered into on November 2, 2026 (Note 16, Subsequent events). It excludes (i) costs of the potential acquisition, which the counterparty is obligated to repay if the acquisition is not completed and which management expects to fund at closing from the proceeds of financing required to complete the acquisition, and (ii) salaries, payroll taxes, and medical coverage, which begin only upon completion of additional fundraising and would be funded from its proceeds. Based on that evaluation, management concluded that conditions and events, considered in the aggregate, do not raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date these condensed financial statements are issued.

 

If the Company were required to fund the costs of the potential acquisition from existing cash without reimbursement, if compensation became payable before additional capital is raised, or if costs significantly exceeded management’s estimates, the Company’s existing cash would not be sufficient to fund its obligations through the end of that period without additional financing or reductions in discretionary expenditures. The company will require additional capital to complete the potential acquisition and to execute its business strategy, and there can be no assurance that such capital will be available on acceptable terms, or at all.

 

 

 10 

 

Note 4 - Revenue

 

During the three months ended September 30, 2026, the Company provided advisory services to Omnitek in connection with Omnitek’s acquisition of Hard Rock Ready Mix, LLC. The services included structuring the capitalization table, procuring legal professionals, making introductions to parties to the transaction, advising on the spin-out of Omnitek’s legacy business, and advising on SEC filing matters. The fee was not related to capital raised. Consideration consisted of $300,000 in cash, received on September 29, 2026 and warrants to purchase 16,666,667 shares of Omnitek common stock, deemed earned on September 29, 2026 and deliverable by October 15, 2026 (Note 5, Investments and fair value measurements).

 

Revenue for the three months ended September 30, 2026 is disaggregated by type of consideration as follows:

       
   Amount
Cash consideration  $300,000 
Noncash consideration – Omnitek fee warrants (16,666,667 shares), at fair value   381,290 
Total advisory fee revenue  $681,290 

 

All revenue was recognized at a point in time and earned in the United States. As of September 30, 2026, the Company had no accounts receivable, contract assets or contract liabilities other than the right to receive the Omnitek fee warrants, which is included in investments at fair value (Note 5, Investments and fair value measurements). No revenue was recognized during the three months ended September 30, 2026 from performance obligations satisfied in prior periods.

 

As of September 30, 2026, the Company had no remaining unsatisfied performance obligations under the Omnitek engagement.

 

Note 5 - Investments and fair value measurements

 

Investments at fair value consist of instruments of Omnitek Engineering Corp. (OTC: OMTK):

                            
Instrument  Shares
underlying
  Fair value at
initial recognition
  Unrealized
gain
  Fair value,
September 30,
2026
Warrants purchased in September 2026 private placement (“Warrant 2026-01”)   91,666,666    550,000    1,551,842    2,101,842 
Fee warrants (“Warrant 2026-02”)   16,666,667    381,290    222    381,512 
Option   4,500,000    62,058    (27)   62,031 
Total   112,833,333   $993,348   $1,552,037   $2,545,385 

 

The $993,348 fair value at initial recognition comprised the $550,000 cash purchase price of Warrant 2026-01, the $62,058 fair value of the option and the $381,290 fair value of Warrant 2026-02, of which $381,290 was recognized as revenue (Note 4, Revenue). The $62,058 recognized at initial recognition of the option and the $1,552,037 change in fair value through September 30, 2026 are included in the $1,614,095 unrealized gain on investments, all of which relates to instruments held as of September 30, 2026.

 

 

 

 11 

 

The Company had the following assets measured at fair value on a recurring basis as of September 30, 2026. There were no assets or liabilities measured at fair value on a recurring basis as of June 30, 2026.

                            
   Level 1  Level 2  Level 3  Total
Investments – Omnitek warrants and option  $–   $–   $2,545,385   $2,545,385 

 

 

Changes in Level 3 assets measured at fair value on a recurring basis for the three months ended September 30, 2026:

       
   Amount
Balance, June 30, 2026  $– 
Purchases   550,000 
Noncash consideration received   381,290 
Unrealized gain included in earnings   1,614,095 
Balance, September 30, 2026  $2,545,385 

 

The Company estimates the fair value of the Omnitek warrants and option using the Black-Scholes option-pricing model. The Omnitek common stock price is an observable input; expected volatility, the expected term and the discount for lack of marketability are unobservable, so the measurements are categorized within Level 3. As of September 30, 2026, the Company used the $0.0299 closing price of Omnitek common stock on that date, when 1,265,665 shares traded in 101 trades following Omnitek’s Current Report on Form 8-K disclosing the transactions. At initial recognition of the option on September 29, 2026, the Company used $0.0299 September 30, 2026 closing price as an adjusted input. The last reported trade before that date $0.0121 on September 25, 2026, preceded the signing and public disclosure of the transactions, and ASC 820 requires a quoted price to be adjusted for significant events that occur after it. Warrant 2026-02, which Omnitek reported as issued to the Company on September 30, 2026 and which bears an issue date of October 1, 2026, has terms similar to Warrant 2026-01. Other inputs were exercise prices of $0.004 per share for the warrants and $0.01 per share for the option; expected terms equal to the remaining contractual terms (warrants expiring September 29, 2031 and October 1, 2031, and the option expiring March 31, 2027); and risk-free interest rates based on U.S. Treasury yields for comparable terms. The warrant shares and option shares are unregistered and may not be resold until the Rule 144 holding period has elapsed, which the Company estimates will occur on March 29, 2027 for Warrant 2026-01, April 1, 2027 for Warrant 2026-02 and approximately September 30, 2027 for shares acquired upon exercise of the option. The Company applied a discount for lack of marketability, estimated using the Finnerty average-strike put model over the period from the measurement date to the earliest resale date, to the Omnitek stock price. No discount was applied for the size of the Company’s holding, and the warrants and option are not subject to any contractual lock-up. The expected term used is the contractual term, consistent with market participant assumptions, rather than the Company’s expected exercise of the instruments within twelve months.

 

The following table presents quantitative information about the significant unobservable inputs used in the Level 3 measurements:

 
Significant unobservable input (Black-Scholes option-pricing model) September 30, 2026 (September 29, 2026)
Expected volatility

136.6%

(136.6%)

Discount for lack of marketability – warrants

20.2% – 20.3%

(20.2% – 20.3%)

Discount for lack of marketability – option

26.1%

(26.1%)

Period to earliest resale under Rule 144 – warrants (years)

0.5

(0.5)

Period to earliest resale under Rule 144 – option (years)

1.0

(1.0)

Expected term – warrants (years)

5.0

(5.0)

Expected term – option (years)

0.5

(0.5)

Risk-free interest rate – warrants

5.09%

(5.06%)

Risk-free interest rate – option

4.31%

(4.36%)

 

 

 

 12 

 

The carrying amounts of cash, prepaid expenses, accounts payable and accrued liabilities approximate fair value because of their short maturities.

 

Note 6 - Equity method investment

 

The Company holds a 19.9% membership interest in Rift, a variable interest entity of which the Company is not the primary beneficiary. The carrying amount of the investment was $39,800 as of both September 30, 2026 and June 30, 2026. No equity in earnings or losses was recognized during the three months ended September 30, 2026 because Rift had no revenue or expenses. Management evaluated the investment for other-than-temporary impairment as of September 30, 2026 and concluded that no impairment existed. The Company’s maximum exposure to loss is limited to the carrying amount.

 

Note 7 - Prepaid expenses

              
   September 30,
2026
  June 30,
2026
Directors’ and officers’ liability insurance  $87,267   $116,357 
Legal retainers   20,000    – 
OTC Market fees   11,503    2,670 
Total prepaid expenses  $118,770   $119,027 

 

Note 8 - Advisory warrants and deferred offering costs

 

Advisory Agreement – warrants

 

On July 20, 2026, the Company entered into an Advisory Agreement with a FINRA registered advisor (the “Advisor”) for advisory services related to M&A and capital-markets strategies. As partial consideration, the Company sold the Advisor and fifteen of its designees warrants to purchase an aggregate of 14,000,000 shares of common stock, at a purchase price of $0.01 per warrant, for cash proceeds of $140,000. Each warrant has an exercise price of $0.01 per share, is exercisable through December 31, 2026, permits cashless exercise and contains customary anti-dilution provisions that adjust the exercise price and number of warrant shares for stock dividends, stock splits, reverse stock splits and reclassifications of the common stock, reduce the exercise price for extraordinary cash dividends and entitle the holder to participate in pro rata purchase rights. The warrants are equity-classified under ASC 815-40.

 

The warrants were fully vested and nonforfeitable at issuance. The Company measured them at their grant-date fair value of $1,802,084 ($0.1287 per warrant) using the Black-Scholes option-pricing model with the following inputs: a common stock price of $0.1382 per share, equal to the $0.2763 volume-weighted average price of the Company’s common stock for the 30 days ended July 20, 2026, reduced by a 50% discount for lack of marketability; an exercise price of $0.01 per share; a term of 0.45 years, equal to the contractual term to December 31, 2026; expected volatility of 200%; a risk-free interest rate of 3.91%; and no expected dividends. The Company used the 30-day volume-weighted average price rather than the July 20, 2026 closing price because the common stock traded in low volume and applied the discount to reflect the restrictions on resale of the shares issuable upon exercise under Rule 144 during the holding period, which the Company estimated would end on April 6, 2027. The measurement is a nonrecurring Level 3 measurement. The $1,662,084 excess of grant-date fair value over the cash received was recognized in additional paid-in capital and charged to professional fees, because the warrants were issued as consideration for services under the Advisory Agreement. As of September 30, 2026, no warrants had been exercised; all of the warrants were exercised on a cashless basis in October 2026 (Note 16, Subsequent events).

 

 

 

 13 

 

Deferred offering costs

 

On July 20, 2026, the Company separately entered into an advisory agreement, under which the advisor is to act as exclusive placement agent for a proposed best-efforts private placement of up to $20 million of the Company’s securities, and paid the advisor a $150,000 non-refundable engagement fee.

 

Note 9 - Accounts payable, accrued liabilities

 

Accounts payable and accrued liabilities were $362,257 and $272,782 as of September 30, 2026 and June 30, 2026, respectively. The September 30, 2026 balance consists principally of legal and accounting fees incurred in connection with a potential business acquisition and the Company’s periodic reporting, together with $24,641 of corporate credit card balances. No compensation was accrued as of September 30, 2026 because salaries under the Company’s offer letters had not begun; under the employees’ November 15, 2026 agreement, they begin the later of January 1, 2027 and the Company’s completion of additional fundraising (Note 3, Liquidity).

 

Note 10 - Related party transactions

 

The Company’s related parties are described in Note 8, Related party transactions, of the 2026 Form 10-K. Related party transactions entered into during the three months ended September 30, 2026 were as follows:

 

Executive compensation

 

On September 1, 2026, the Company entered into at-will offer letters with David Wachsman, President, at an annual salary of $360,000; Q. Byron Hamlett, Chief Financial Officer (employed as Vice President), at an annual salary of $270,000; and Derek Wachsman, the President’s brother, as Vice President, at an annual salary of $150,000. No compensation was accrued for these individuals as of September 30, 2026. On November 15, 2026, these individuals and the Company’s other employee agreed to the Company’s deferral of the start of their compensation until the later of January 1, 2027 and the Company’s completion of additional fundraising (Note 16, Subsequent events).

 

Interests in controlling stockholder

 

David Wachsman, President, and Q. Byron Hamlett, Chief Financial Officer, each hold a minority membership interest in HH, which owned approximately 91% of the Company’s outstanding common stock as of September 30, 2026 and approximately 87% as of November 12, 2026, after the issuance of shares upon exercise of the advisory warrants (Note 16, Subsequent events). Martin Sumichrast, Chairman of the Board, is the manager of MCIMAC, LLC, which is the manager of HH (Note 1, Description of business).

 

Note 11 - Stockholders’ equity

 

Authorized capital

 

On August 20, 2026, the Amended and Restated Articles of Incorporation became effective, increasing authorized common stock from 400,000,000 to 10,000,000,000 shares. Authorized preferred stock remained 50,000,000 shares. The Board retains discretion through June 17, 2027 to effect a reverse stock split at a ratio of between 1-for-2 and 1-for-20; no reverse split had been effected as of the date of this report.

 

 

 

 14 

 

Common stock

 

No shares of common stock were issued during the three months ended September 30, 2026. As of September 30, 2026 and June 30, 2026, there were 266,052,926 shares outstanding. In addition to the 266,052,926 shares of common stock issued and outstanding as of September 30, 2026, 450,000 fully vested shares (200,000 to government affairs consultant and 250,000 to investor relations consultant) were to be issued. As of November 12, 2026, 279,771,362 shares were issued and outstanding, reflecting the 13,718,436 shares issued in October 2026 upon the cashless exercise of the advisory warrants; the 450,000 shares to be issued had not yet been issued.

 

Stock purchase warrants

 

Warrant activity for the three months ended September 30, 2026:

               
   Shares  Weighted-average
exercise price
  Remaining term
(years)
Outstanding, June 30, 2026   –    –      
Issued – advisory warrants (Note 8)   14,000,000   $0.01      
Exercised / expired   –    –      
Outstanding and exercisable, September 30, 2026   14,000,000   $0.01    0.25 

 

Stock options

 

No options were granted, exercised or forfeited during the three months ended September 30, 2026. As of September 30, 2026, options to purchase 115,000 shares with a weighted-average exercise price of $0.70 and a weighted-average remaining contractual term of 0.56 years were outstanding and exercisable, with an aggregate intrinsic value of $41,000 based on the $0.91 closing price of the Company’s common stock on September 30, 2026. Options to purchase 15,000 shares expired unexercised on October 1, 2026. No awards have been granted under the 2026 Equity Incentive Plan.

 

Share-based compensation

 

The Company recognized share-based payment expense of $1,697,682 during the three months ended September 30, 2026, consisting of $1,662,084 for the warrants issued to the Advisor and its designees for advisory services, included in professional fees (Note 8, Advisory warrants and deferred offering costs), and $35,598 for the investor relations consultant shares described below, included in sales and marketing. No share-based compensation expense was recognized during the three months ended September 30, 2025. Consistent with SEC Staff Accounting Bulletin Topic 14.F, share-based payment expense is presented in the same line items as cash consideration for the same services rather than as a separate line item.

 

Investor relations consultant shares

 

On July 14, 2026, the Company entered into an Investor Relations Agreement with an investor relations consultant with an initial term of six months that renews automatically for successive six-month terms unless either party gives notice of non-renewal. As compensation, the Company pays the consultant $10,000 per month and agreed to issue 250,000 shares of restricted common stock, which were deemed earned upon execution of the agreement. The shares are a share-based payment to a nonemployee under ASC 718, Compensation—Stock Compensation. Because the shares were fully vested and nonforfeitable on the grant date, the Company measured them at their grant-date fair value of $35,598 ($0.1424 per share, equal to the $0.2848 volume-weighted average price of the Company’s common stock for the 30 days ended July 14, 2026, reduced by a 50% discount for lack of marketability to reflect the restrictions on resale of the shares under Rule 144 during the holding period of six months after issuance) and recognized the full amount as sales and marketing expense during the three months ended September 30, 2026. As of September 30, 2026 and the date of this report, the shares had not been issued, and their grant-date fair value of $35,598 is included in stock to be issued. The Company has notified consultant that it is suspending the contract effective September 1, 2026 until further notice.

 

 

 

 15 

 

Note 12 - Income taxes

 

The Company calculates its interim income tax provision under ASC 740-270 by applying an estimated annual effective tax rate to year-to-date ordinary income and recognizing the tax effect of discrete items in the period in which they occur. The Company recorded no provision for income taxes for the three months ended September 30, 2026 and 2025. The estimated annual effective tax rate for fiscal 2027 is 0%, which differs from the 21% federal statutory rate principally because of the change in the valuation allowance on the Company’s deferred tax assets. The Company’s effective tax rate was 0% for each of the three months ended September 30, 2026 and 2025.

 

As described in Note 12, Income taxes, of the fiscal year 2026 Form 10-K, the change in control in fiscal year 2026 resulted in an ownership change under Section 382 of the Internal Revenue Code, and the Company is completing an analysis to determine the resulting limitation on its pre-change net operating loss carryforwards. The unrealized gain on investments and the noncash consideration received during the quarter create taxable temporary differences. The Company has not filed its federal and state income tax returns for the tax year ended June 30, 2023 or any subsequent tax year. No liability for related penalties or interest has been recorded because the amount, if any, cannot be reasonably estimated.

 

Note 13 - Commitments and contingencies

 

Litigation

 

From time to time, the Company may be subject to claims arising in the ordinary course of business. The Company is not a party to any material pending legal proceeding and is not aware of any asserted or unasserted claims that management believes would have a material adverse effect on its financial position, results of operations or cash flows.

 

Employment arrangements

 

Under at-will offer letters effective September 1, 2026, salaries at an aggregate annual rate of $900,000 beginning the later of January 1, 2027 and the Company’s completion of additional fundraising, under the employees’ November 15, 2026 agreement to the deferral of the start of their compensation (Note 3, Liquidity); no compensation was accrued as of September 30, 2026. The offer letters are terminable at will, and employee medical coverage begins when salaries begin.

 

Potential recovery of acquisition costs

 

During the three months ended September 30, 2026, the Company advanced $110,000 for transaction costs of the potential business acquisition it is pursuing, including $60,000 advanced to the counterparty, and expensed those advances within acquisition-related costs in the condensed statements of operations. Under the letter of intent for the potential acquisition, the advances are subject to repayment (clawback) by the counterparty if the acquisition is not completed, and the counterparty has also agreed to reimburse the Company’s other transaction costs in that event. Any recovery depends on the acquisition not being completed and on the counterparty’s ability to pay, and is therefore a gain contingency under ASC 450-30, Gain Contingencies. The Company has not recognized a receivable for any potential recovery and will recognize a recovery only when it is realized or realizable. There can be no assurance that any amount will be recovered.

 

Indemnification

 

The Advisory Agreement contains customary indemnification of the Advisor and its affiliates. The Company has not accrued any indemnification liability.

 

 

 

 16 

 

Escrow deposit

 

As disclosed in the 2026 Form 10-K, the Company had deposited $550,000 into escrow in connection with a non-binding letter of intent. On September 29, 2026, the escrowed funds were applied to the purchase of Omnitek stock purchase warrants in Omnitek’s private placement, see Note 5, Investments and fair value measurements.

 

Unfiled tax returns

 

See Note 12, Income taxes, regarding possible penalties and interest associated with delinquent income tax returns, the amount of which cannot be reasonably estimated.

 

Note 14 - Net loss per share

 

Basic net loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period, including shares issuable for little or no cash consideration are included from the date all necessary conditions are satisfied. Diluted net loss per common share includes the effect of potential common shares only when their inclusion is dilutive. Because the Company reported a net loss for the three months ended September 30, 2026 and 2025, potential common shares were excluded from diluted net loss per share because their effect would have been anti-dilutive.

 

The following table reconciles the numerator and denominator used in the basic and diluted net loss per common share calculations:

          
  Three Months Ended
  September 30,
2026
  September 30,
2025
Net income (loss)  $(146,911)  $(101,533)
Weighted-average common shares outstanding – basic   277,576,296    8,706,772 
Effect of dilutive potential common shares   –    – 
Weighted-average common shares outstanding – diluted   277,576,296    8,706,772 
Net loss per share – basic and diluted  $(0.00)  $(0.01)

 

The following potentially dilutive securities were excluded from the computation of diluted net loss per share because their effect would have been anti-dilutive:

Schedule of antidilutive securities               
   Three Months Ended
   September 30, 2026  September 30, 2025
Stock options (weighted-average exercise price $0.70 and $0.98, respectively)   115,000    322,600 
Stock to be issued – Rift intellectual property (as previously reported)   –    500,000 
Total potential dilutive securities excluded   115,000    822,600 

 

The weighted-average common shares outstanding for the three months ended September 30, 2026 include, in addition to the 266,052,926 shares issued and outstanding, the 450,000 fully vested shares to be issued (200,000 shares to the government affairs consultant from July 1, 2026 and 250,000 shares to the investor relations consultant from July 14, 2026) and the 14,000,000 shares issuable upon exercise of the advisory warrants at an exercise price of $0.01 per share from their July 20, 2026 issuance date, which together added 11,523,370 weighted-average shares. These shares are not included in the shares issued and outstanding presented in the balance sheet.

 

In the Company’s financial statements for the year ended June 30, 2026, the 200,000 shares to be issued to the government affairs consultant were presented as potentially dilutive securities, and the shares issuable upon exercise of the HH Warrant ($0.01 exercise price) were included from its June 11, 2026 exercise date rather than its June 3, 2026 issuance date. Including those shares from the dates all necessary conditions were satisfied would not have changed the reported basic and diluted net loss per share of $(0.02) for fiscal year 2026. The weighted-average common shares outstanding for the three months ended September 30, 2025 are presented as previously reported and exclude the 500,000 shares to be issued for the Rift intellectual property; including them would not have changed the reported net loss per share of $(0.01).

 

 

 

 17 

 

Note 15 - Segment information

 

The Company has one operating and reportable segment. The Company’s President is the chief operating decision maker (“CODM”). The CODM assesses performance and decides how to allocate resources based on net loss as reported on the statements of operations, which the CODM uses to monitor actual results against the Company’s budget and to make decisions about the pursuit of advisory engagements, investments and acquisitions, and the hiring of personnel. Significant segment expenses regularly provided to the CODM are presented below. The measure of segment assets is total assets as reported on the balance sheets, which were $4,044,416 and $2,264,170 as of September 30, 2026 and June 30, 2026, respectively.

          
   Three Months Ended
September 30,
2026
  Three Months Ended
September 30,
2025
Revenue  $681,290   $– 
Less significant segment expenses:
          
Professional fees   1,899,912    27,127 
Acquisition-related costs   394,193    – 
Sales and marketing   58,153    – 
General and administrative   100,805    6,380 
Other segment items (1)   (1,624,862)   68,026 
Segment net loss  $(146,911)  $(101,533)

_________________ 

(1) Other segment items consist of interest income, interest expense, related-party interest expense and the unrealized gain on investments.

 

Note 16 - Subsequent events

 

The Company evaluated subsequent events through November 16, 2026, the date these condensed financial statements were issued.

 

Director resignation

 

On October 29, 2026, Corby Marshall resigned from the Board of Directors. His resignation was not due to any disagreement with the Company.

 

Deferral of compensation

 

On November 15, 2026, the four employees agreed to the Company’s deferral of the start of their compensation until the later of January 1, 2027 and the Company’s completion of additional fundraising. Under the offer letters effective September 1, 2026, salaries at an aggregate annual rate of $900,000 were to begin upon completion of additional fundraising; no compensation was earned or accrued as of September 30, 2026 (Note 3, Liquidity).

 

 

 

 18 

 

Advisory warrants

 

In October 2026, the Advisor and its designees exercised all 14,000,000 warrants in full on a cashless basis. The Company issued an aggregate of 13,718,436 shares of common stock on October 13 and 14, 2026 upon those exercises, and the holders surrendered the right to purchase 281,564 warrant shares as the cashless exercise adjustment. The Company received no cash upon exercise, and no warrants remain outstanding.

 

Tokenization of stock

 

On November 2, 2026, the Company entered into a Tokenization Agreement with Securitize Transfer Agent, LLC (“Securitize”), under which Securitize will act as co-transfer agent, registrar and tokenization agent for the Company’s common stock alongside the Company’s existing transfer agent. Under the agreement, shares of the Company’s common stock may be issued, recorded and transferred as digital tokens on the Ethereum blockchain; the tokens represent shares of the Company’s existing common stock and do not create a new class of securities. The agreement has an initial term of twelve months, renews automatically for successive one-year terms unless either party gives notice of non-renewal, or may be terminated by the Company for convenience on 30 days’ notice. Fees include a $75,000 set-up fee payable upon execution of the agreement; a token issuance fee for each blockchain on which the common stock is deployed; a monthly servicing fee through December 31, 2027; and per-investor, per-event and blockchain transaction fees. The Company will recognize these fees as expense as the services are received.

 

 

 

 

 

 

 

 

 19 

 

NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q, the other reports, statements, and information that we have previously filed or that we may subsequently file with the Securities and Exchange Commission (the “SEC”), and public announcements that we have previously made or may subsequently make include, may include, incorporate by reference or may incorporate by reference certain statements that may be deemed to be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and are intended to enjoy the benefits of that act. Unless the context is otherwise, the forward-looking statements included or incorporated by reference in this Quarterly Report on Form 10-Q and those reports, statements, information and announcements address activities, events or developments that Hawkeye Digital, Inc. (hereinafter referred to as “we,” “us,” “our,” the “Company” or “Hawkeye”) expects or anticipates, will or may occur in the future. Any statements in this document about expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as “may,” “should,” “could,” “predict,” “potential,” “believe,” “will likely result,” “expect,” “will continue,” “anticipate,” “seek,” “estimate,” “intend,” “plan,” “projection,” “would” and “outlook,” and similar expressions. Accordingly, these statements involve estimates, assumptions, and uncertainties, which could cause actual results to differ materially from those expressed in them. All forward-looking statements concerning economic conditions, rates of growth, rates of income or values as may be included in this document are based on information available to us on the dates noted, and we assume no obligation to update any such forward-looking statements. It is important to note that our actual results may differ materially from those in such forward-looking statements due to fluctuations in interest rates, inflation, government regulations, economic conditions and competitive product and pricing pressures in the geographic and business areas in which we conduct operations, including our plans, objectives, expectations and intentions and other factors discussed elsewhere in this quarterly report.

 

Certain risk factors could materially and adversely affect our business, financial condition and results of operations and cause actual results or outcomes to differ materially from those expressed in any forward-looking statements made by us, and you should not place undue reliance on any such forward-looking statements. These risks include those described under “Risk Factors” in Part II, Item 1A of this Quarterly Report on Form 10-Q and in Part I, Item 1A of our Annual Report on Form 10-K for the year ended June 30, 2026 (the “2026 Form 10-K”). Any forward-looking statement speaks only as of the date on which it is made, and we do not undertake any obligation to update any forward-looking statement or statements to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of unanticipated events, except as required by law. New factors emerge from time to time, and it is not possible for us to predict which will arise. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

 

 

 

 20 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

You should read the following discussion and analysis of our financial condition and results of operations in conjunction with the unaudited condensed financial statements and the notes thereto included in Part I, Item 1 of this Quarterly Report on Form 10-Q and with our audited financial statements and Management’s Discussion and Analysis for the year ended June 30, 2026 included in our 2026 Form 10-K. Some of the information contained in this discussion and analysis, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks, uncertainties and assumptions. You should read “Special Note Regarding Forward-Looking Statements” and “Risk Factors” in Part II, Item 1A of this Quarterly Report on Form 10-Q for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.

 

The following discussion relates to the historical operations and financial statements of Hawkeye Digital, Inc. for the three months ended September 30, 2026 and 2025.

 

Overview

 

From inception until July 2021, we focused on selling personal protective equipment. We underwent a change in control effective April 1, 2026, after which our strategy focuses on operating as a private equity and corporate advisory firm conducting merchant banking services in digital assets and other frontier verticals in financial services and technology. Our controlling stockholder, Hawkeye Holdco LLC (“HH”), owned approximately 87% of our outstanding common stock as of November 12, 2026. In connection with this realignment of our business strategy, we intend to raise capital to invest in and potentially acquire controlling interests in companies that fit our investment criteria (each, a “target business”), as well as recruit and retain additional personnel to provide companies with business advisory services. We are not registered as a broker-dealer and intend to conduct activities requiring registration only through appropriately registered entities.

 

We hold a 19.9% membership interest in Rift Cyber LLC (“Rift”), which is developing a unified smart sensor platform, Rythe, at the intersection of physical security and cybersecurity. Rift has not generated revenue, and we account for our interest under the equity method.

 

The three months ended September 30, 2026 were our first full quarter executing this strategy. Significant developments during the quarter included the following:

 

·First advisory engagement. We completed an advisory engagement for Omnitek Engineering Corp. (OTC: OMTK) (“Omnitek”) in connection with Omnitek’s acquisition of Hard Rock Ready Mix, LLC and recognized advisory fee revenue of $681,290, consisting of $300,000 in cash and $381,290 in Omnitek warrants measured at fair value. We also purchased Omnitek warrants for $550,000 in September 2026.
   
·Corporate actions. On August 20, 2026, our Amended and Restated Articles of Incorporation became effective, changing our name from Hawkeye Systems, Inc. to Hawkeye Digital, Inc., increasing our authorized common stock to 10,000,000,000 shares and classifying our Board of Directors.
   
·Employees. Effective September 1, 2026, we entered into at-will offer letters with four individuals, including our President and Chief Financial Officer, at an aggregate annual salary rate of $900,000. No compensation was accrued for the quarter. On November 15, 2026, the four employees agreed to our deferral of the start of their compensation until the later of January 1, 2027 and the Company’s completion of additional fundraising.

 

 

 

 21 

 

·Potential acquisition. We are pursuing a potential business acquisition under a non-binding letter of intent and incurred $394,193 of legal, accounting, audit, quality-of-earnings and other costs in connection with it. Completion is subject to, among other things, our obtaining the financing necessary to complete it.

 

Our financial results are, and we expect them to continue to be, primarily driven by:

 

·the number, size and timing of the advisory engagements we complete, which depend on the closing of client transactions;
   
·the form of the consideration we receive, including the portion paid in securities of our clients rather than in cash;
   
·changes in the fair value of client securities we hold, which are remeasured through earnings each quarter;
   
·the costs of pursuing acquisitions, including the potential acquisition described above, which we expense as incurred whether or not a transaction is completed; and
   
·compensation and other costs of building our team, and our ability to raise capital to fund our strategy.

 

Results of Operations – Three Months Ended September 30, 2026 Compared with September 30, 2025

 

   2026  2025  $ Change  % Change
Advisory fee revenue  $681,290   $–   $681,290    n/m 
Professional fees   1,899,912    27,127    1,872,785    6,904% 
Acquisition-related costs   394,193    –    394,193    n/m 
Sales and marketing   58,153    –    58,153    n/m 
General and administrative   100,805    6,380    94,425    1,480% 
Total operating expenses   2,453,063    33,507    2,419,556    7,221% 
Loss from operations   (1,771,773)   (33,507)   (1,738,266)   n/m 
Interest income   11,283    –    11,283    n/m 
Interest expense, including related party   (516)   (68,026)   67,510    99% 
Unrealized gain on investments   1,614,095    –    1,614,095    n/m 
Total other income (expense), net   1,624,862    (68,026)   1,692,888    n/m 
Provision for income taxes   –    –    –    – 
Net loss  $(146,911)  $(101,533)  $(45,378)   n/m 

n/m – not meaningful.

 

Revenue

 

Advisory fee revenue of $681,290 for the three months ended September 30, 2026 was earned entirely from the Omnitek engagement (Note 4). We had no revenue in the prior-year quarter. Revenue comprised $300,000 of cash received on September 29, 2026 and $381,290 of noncash consideration: warrants to purchase 16,666,667 shares of Omnitek common stock, measured at fair value. Our advisory revenue depends on the completion of discrete transactions, is concentrated in a single client for the quarter, and is not expected to be consistent from quarter to quarter.

 

 

 

 22 

 

Operating expenses

 

Total operating expenses increased $2,419,556, to $2,453,063 from $33,507, as we began executing our strategy. The principal changes were:

 

·Acquisition-related costs of $394,193 consisted of legal, audit, quality-of-earnings and other professional fees incurred in connection with the potential business acquisition we are pursuing. These costs are expensed as incurred. The counterparty has agreed to reimburse transaction costs we have incurred if the acquisition is not completed; we will not recognize any reimbursement until our right to it is established. These costs include $110,000 of transaction costs we advanced during the quarter, which are subject to clawback under the letter of intent if the acquisition is not completed (Note 13, Commitments and contingencies). We expect to continue to incur such costs until the proposed transaction is completed or abandoned, and we do not expect them to recur thereafter.
   
·Professional fees increased $1,872,785, to $1,899,912 from $27,127, primarily because of the $1,662,084 grant-date fair value of the warrants issued to the Advisor and its designees in excess of the cash received, which we recognized as expense (Note 8), legal fees for corporate, securities and regulatory matters ($72,009), and accounting and audit fees ($93,125, principally the audit of our fiscal 2026 financial statements) and consulting fees for software development, reputation management and communications ($37,720), as we transitioned to an advisory business.
   
·General and administrative expense increased $94,425, to $100,805 from $6,380, primarily because of travel and related costs ($56,118, including meals) associated with business development, amortization of directors’ and officers’ liability insurance ($29,089) that we did not carry in the prior-year quarter, and public-company, OTC Markets and transfer agent costs ($9,409).
   
·Sales and marketing expense of $58,153 consisted primarily of investor relations consulting services ($45,598, comprising $10,000 of cash fees and $35,598 of noncash expense for 250,000 shares of common stock to be issued as compensation), LinkedIn recruiting and advertising, and conference attendance.

 

Other income (expense), net

 

Other income, net, was $1,624,862, compared with other expense, net, of $68,026 in the prior-year quarter. The current quarter consisted principally of a $1,614,095 unrealized gain on the Omnitek warrants and option, comprising $62,058 recognized at initial recognition of the option and $1,552,037 from the remeasurement of the Omnitek instruments to fair value as of September 30, 2026, and $11,283 of interest income on money market balances. The prior-year quarter consisted of interest on the related-party promissory note, which was purchased by HH, exchanged and converted into common stock during the fourth quarter of fiscal 2026; we had no indebtedness during the current quarter. The unrealized gain depends on the market price of Omnitek’s thinly traded common stock and on significant unobservable inputs, and it may reverse in future periods.

 

Income taxes

 

We recorded no provision for income taxes for either period, and our effective tax rate was 0% for both periods. Our estimated annual effective tax rate for fiscal 2027 reflects the expected change in the valuation allowance on our deferred tax assets, which remain subject to the Section 382 limitation arising from our change in control (Note 12, Income taxes).

 

Net loss

 

We reported a net loss of $146,911, or $(0.00) per basic and diluted share, compared with a net loss of $101,533, or $(0.01) per share, in the prior-year quarter. Our results for the quarter were driven largely by noncash items: noncash advisory revenue of $381,290 and the unrealized gain on investments of $1,614,095 together contributed $1,995,385 to our results, more than offset by $1,697,682 of noncash share-based payment expense, and net cash used in operating activities was $354,882 (see “Liquidity and Capital Resources”). Weighted-average shares outstanding increased to 277,576,296 from 8,706,772, principally because of the 255,017,296 shares issued in June 2026 in connection with our change in control.

 

 

 

 23 

 

Non-GAAP Financial Measure – Adjusted EBITDA

 

In addition to our results determined in accordance with U.S. GAAP, we use Adjusted EBITDA, a non-GAAP financial measure, to evaluate the performance of our advisory operations. EBITDA and Adjusted EBITDA are not measurements of our financial performance under U.S. GAAP and EBITDA and Adjusted EBITDA have limitations as an analytical tool and should not be considered in isolation or as a substitute for net loss or other measures prepared in accordance with U.S. GAAP. We define Adjusted EBITDA as net loss before interest expense, interest income, provision for income taxes and depreciation and amortization (“EBITDA”), further adjusted to exclude share-based payment expense, unrealized gains and losses on our investments in client securities, and acquisition-related costs. We believe Adjusted EBITDA is useful to investors because it excludes items that can vary significantly from period to period for reasons unrelated to the performance of our advisory operations:

 

·Share-based payments. We exclude the expense for equity instruments issued for services, consisting of the warrants issued under our Advisory Agreement ($1,662,084) and the shares to be issued to investor relations consultant ($35,598). The expense is noncash, is measured using our stock price and Level 3 valuation inputs at the grant date, and varies with the timing, size and nature of awards.
   
·Unrealized gains and losses on investments. We exclude changes in the fair value of the Omnitek warrants and option after initial recognition. These gains are noncash, depend on the price of Omnitek’s thinly traded common stock, and may reverse before the instruments are exercised and the underlying shares are sold.
   
·Acquisition-related costs. We exclude legal, audit, quality-of-earnings and other costs of the potential business acquisition we are pursuing, which we do not consider costs of operating our advisory business and which are subject to clawback or reimbursement if the acquisition is not completed (Note 13 to the condensed financial statements).

 

We caution investors that amounts presented in accordance with our definitions of Adjusted EBITDA may not be comparable to similar measures disclosed by our competitors, because not all companies and analysts calculate the Adjusted EBITDA in the same manner. We present the EBITDA and Adjusted EBITDA because we consider them to be important supplemental measures of our performance and believe they are frequently used by securities analysts, investors, and other interested parties in the evaluation of companies in our industry. Management believes that investors’ understanding of our performance is enhanced by including EBITDA and Adjusted EBITDA as a reasonable basis for comparing our ongoing results of operations.

 

Management uses EBITDA and Adjusted EBITDA:

 

  · as measurements of operating performance because they assist us in comparing the operating performance of our business on a consistent basis, as they remove the impact of items not directly resulting from our core operations;
     
  · for planning purposes, including the preparation of our internal annual operating budget and financial projections;
     
  · to evaluate the performance and effectiveness of our operational strategies; and
     
  · to evaluate our capacity to expand our business.

 

By providing these Non-GAAP Financial Measures, together with reconciliations, we believe we are enhancing investors’ understanding of our business and our results of operations, as well as assisting investors in evaluating how well we are executing our strategic initiatives. 

 

 

 24 

 

Some of the limitations are:

 

  · such measures do not reflect our cash expenditures, or future requirements for capital expenditures or contractual commitments;
     
  · such measures do not reflect changes in, or cash requirements for, our working capital needs;
     
  · Such measures do not reflect the interest expense, or the cash requirements necessary to service interest or principal payments on our debt;
     
  · although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future and such measures do not reflect any cash requirements for such replacements;
     
  · certain of the items excluded in arriving at such measures require settlement in cash, and excluding an item does not reduce the cash we are required to pay in respect of that item; and
     
  · other companies in our industry may calculate such measures differently than we do, limiting their usefulness as comparative measures.

 

Due to these limitations, these non-GAAP financial measures should not be considered as measures of discretionary cash available to us to invest in the growth of our business. We compensate for these limitations by relying primarily on our U.S. GAAP results and using these non-GAAP measures only as a supplement. As noted in the tables below, these non-GAAP financial measures include adjustments for non-cash charges related to share based compensation, unrealized gain on investments and acquisition related costs. It is reasonable to expect that certain of these items will occur in future periods. However, we believe these adjustments are appropriate because the amounts recognized can vary significantly from period to period, do not directly relate to the ongoing operations of our business and complicate comparisons of our internal operating results and operating results of other companies over time. Each of the adjustments described herein and in the reconciliation tables below help management with a measure of our core operating performance over time by removing items that are not related to day-to-day operations.

 

Adjusted EBITDA does not adjust our revenue: it includes $381,290 of advisory revenue we received in the form of Omnitek securities, which has not been converted to cash and whose realizable value depends on the Omnitek stock price. Adjusted EBITDA also does not reflect the cash we paid for acquisition-related costs or our cash requirements for working capital.

 

The following table reconciles net loss, the most directly comparable GAAP measure, to Adjusted EBITDA:

 

  Three Months Ended
  September 30,
2026
  September 30,
2025
Net loss (GAAP)  $(146,911)  $(101,533)
Interest expense, including related party   516    68,026 
Interest income   (11,283)   – 
Provision for income taxes   –    – 
Depreciation and amortization   –    – 
EBITDA (non-GAAP)   (157,678)   (33,507)
Share-based payments (Notes 8 and 11)   1,697,682    – 
Unrealized gain on investments in Omnitek securities (Note 5)   (1,614,095)   – 
Acquisition-related costs   394,193    – 
Adjusted EBITDA (non-GAAP)  $320,102   $(33,507)

 

Adjusted EBITDA was $320,102 for the three months ended September 30, 2026, compared with $(33,507) for the prior-year quarter, while our net loss was $146,911 and $101,533, respectively. The change reflects the $681,290 of advisory revenue from our first engagement, of which $381,290 was received in the form of Omnitek securities, partially offset by higher professional, general and administrative and sales and marketing expenses as we began executing our strategy. In the prior-year quarter, the only adjustment was interest expense on a related-party note. Net cash used in operating activities was $354,882 in the current quarter (see “Liquidity and Capital Resources”).

 

 

 

 25 

 

Financial Condition

 

   September 30,
2026
  June 30,
2026
  $ Change  % Change
Cash  $1,190,461   $2,105,343   $(914,882)   (43)%
Prepaid expenses   118,770    119,027    (257)   (0)%
Investments, at fair value   2,545,385    –    2,545,385    n/m 
Equity method investment – Rift   39,800    39,800    –    n/m 
Deferred offering costs   150,000    –    150,000    n/m 
Total assets   4,044,416    2,264,170    1,780,246    79% 
Total current liabilities   362,257    272,782    89,475    33% 
Working capital, excluding Omnitek investments, deferred offering costs   946,974    1,951,588    (1,004,614)   (51)%
Total stockholders’ equity  $3,682,159   $1,991,388   $1,690,771    85% 

n/m – not meaningful.

 

Total assets increased $1,780,246 during the quarter, principally because of the Omnitek warrants and option, which are carried at a fair value of $2,545,385, and the $150,000 engagement fee paid to the Advisor, recorded as deferred offering costs, partially offset by the $914,882 decrease in cash. Total stockholders’ equity increased $1,690,771, reflecting the $1,802,084 grant-date fair value of the advisory warrants recorded in additional paid-in capital and the $35,598 grant-date fair value of common stock to be issued, partially offset by our net loss of $146,911. As of September 30, 2026, approximately 63% of our total assets consisted of the Omnitek instruments and approximately 4% consisted of deferred offering costs; neither is a source of near-term liquidity.

 

Liquidity and Capital Resources

 

As of September 30, 2026, we had cash of $1,190,461, compared with $2,105,343 as of June 30, 2026. We had working capital of $3,642,359, or $946,974 excluding $2,545,385 of Omnitek investments, which are restricted and not readily convertible into cash, and $150,000 of deferred offering costs, which will not be realized in cash, no outstanding indebtedness and total liabilities of $362,257, consisting of accounts payable and accrued liabilities of $362,257. We also held Omnitek warrants and an option with an estimated fair value of $2,545,385. These instruments are not traded on an exchange, may be subject to transfer restrictions, and any sale of the underlying Omnitek shares would depend on the limited trading volume in Omnitek’s common stock. We may not be able to convert them into cash at their carrying value, or at all, and we have not included them in our assessment of the cash available to fund our operations.

 

Cash flows for the three months ended September 30,  2026  2025
Net cash used in operating activities  $(354,882)  $(59,611)
Net cash used in investing activities   (550,000)   (10,000)
Net cash provided by (used in) financing activities   (10,000)   69,427 
Net change in cash  $(914,882)  $(184)

 

Operating activities

 

Net cash used in operating activities was $354,882, compared with $59,611 in the prior-year quarter. Our net loss of $146,911 included $1,697,682 of noncash share-based payment expense and $1,995,385 of noncash revenue and unrealized gains. Prepaid expenses were substantially unchanged, as new legal retainers and prepaid fees were offset by amortization of prepaid directors’ and officers’ liability insurance. These uses were partially offset by an increase of $89,475 in accounts payable and accrued liabilities. During the first quarter, cash used in operating activities included approximately $112,650 of costs paid in connection with the potential acquisition, none of which we expect to recur.

 

 

 

 26 

 

Investing activities

 

Cash used in investing activities was $550,000, reflecting our purchase of Omnitek warrants in Omnitek’s September 2026 private placement. These were the funds previously held in escrow, as disclosed in our 2026 Form 10-K. In the prior-year quarter, we used $10,000 for third-party development costs associated with Rift technology, which were capitalized into our investment in Rift at that time and expensed in fiscal 2026.

 

Financing activities

 

Net cash used in financing activities was $10,000: we received $140,000 from the sale of warrants to the Advisor and its designees under our Advisory Agreement and, separately, paid the Advisor a $150,000 non-refundable engagement fee under our private placement agreement, which we recorded as a deferred offering cost. In October 2026, all 14,000,000 warrants were exercised on a cashless basis, and we received no cash upon exercise. In the prior-year quarter, financing activities consisted of $69,427 of advances under a related-party promissory note, which arrangement no longer exists.

 

During the three months ended September 30, 2026 and 2025, we received $0 and $69,427, respectively, from related parties.

 

Plan of Operation and Funding

 

Executing our business strategy at the scale we contemplate — including completing the potential acquisition we are pursuing, exploring the acquisition of a FINRA-registered broker-dealer, recruiting and retaining investment and advisory personnel, and any further investment in Rift — will require capital in excess of our existing resources. Most of those initiatives are discretionary and within management’s control to defer. We expect to fund them through a combination of existing cash, cash advisory fees, the monetization of securities received as fees, and the sale of equity or debt securities. Separately from our Advisory Agreement, we have engaged an advisor in connection with proposed offerings of our securities. The size, pricing, nature and timing of any offering have not been determined and will depend on market conditions and other factors. There can be no assurance that either offering will be completed. We have no lines of credit or other bank financing arrangements, and no commitment from any party to provide additional financing.

 

Additional issuances of equity or convertible debt securities will result in dilution to our current stockholders, and that dilution could be substantial. Our authorized common stock is 10,000,000,000 shares, and we may issue a significant number of additional shares without further stockholder approval. Securities issued in future financings might have rights, preferences, or privileges senior to our common stock. Additional financing may not be available on acceptable terms, or at all.

 

 

 

 27 

 

Future Capital Requirements

 

We anticipate that our future capital requirements will principally consist of funds required for:

 

·operating, public-company and general corporate expenses, including legal, accounting and audit fees;
   
·

salaries, at an aggregate annual rate of $900,000, together with employee medical coverage beginning the later of January 1, 2027 and the Company’s completion of additional fundraising, and in addition to any additional employees that we may hire in connection with expanding our merchant banking business;

   
·costs of the potential acquisition we are pursuing (to the extent not reimbursed or funded at closing), including legal, audit and quality-of-earnings fees, and any cash consideration payable if the acquisition is completed;
   
·

the potential acquisition and operation of a FINRA-registered broker-dealer or other businesses;

   
·investments in securities of our clients, such as our $550,000 purchase of Omnitek warrants during the quarter, and any further investment in Rift; and
   
·

fees payable to advisors in connection with any future offering of our securities.

 

Uncertainties and Trends Affecting Liquidity

 

Our assessment of our liquidity does not take into account events beyond our control, the completion of any acquisition, or other unanticipated uses of cash, any of which could require us to raise additional capital sooner than we expect. Our ability to raise additional capital, if necessary, is subject to a variety of factors that we cannot predict with certainty, including:

 

·the market price and trading volume of our common stock, which is quoted on the OTCID Basic Market;
   
·the market price of Omnitek’s common stock and our ability to sell the Omnitek securities we hold;
   
·our ability to secure advisory engagements that pay fees in cash;
   
·the volatility and overall condition of the capital markets; and
   
·the willingness of our controlling stockholder and other investors to provide financing.

 

Liquidity Outlook

 

Management has evaluated whether conditions and events, considered in the aggregate, raise substantial doubt about our ability to continue as a going concern within one year after the date the condensed financial statements included in this report are issued (Note 3, Liquidity). The evaluation relies on our existing cash alone. Our cash flow projection through that date includes our recurring costs of maintaining our corporate existence and public reporting of approximately $105,000 per quarter, ongoing discretionary business development spending of approximately $47,000 per quarter, payment of accounts payable outstanding as of September 30, 2026 other than costs of the potential acquisition, the cost of filing our delinquent income tax returns, and the fees under our November 2, 2026 tokenization agreement. It assumes no future advisory fees, no proceeds from any financing and no sale of the Omnitek securities. It excludes the costs of the potential acquisition, which the counterparty is obligated to repay if the acquisition is not completed and which we expect to fund at closing from the proceeds of the financing required to complete it. It also excludes salaries, payroll taxes, and medical coverage, which begin on the later of January 1, 2027 and the Company’s completion of additional fundraising and would be funded from its proceeds. On that basis, we expect our existing cash to be sufficient to meet our obligations as they become due through that date, with approximately $243,000 remaining, and our monthly costs could exceed the projection by approximately 50% before our cash would be exhausted within that period. Management therefore concluded that conditions and events, considered in the aggregate, do not raise substantial doubt about our ability to continue as a going concern.

 

That conclusion depends on two judgements: that we will not pay the costs of the potential acquisition from existing cash within that period, and that compensation will not become payable before we raise additional capital. If we were required to fund those acquisition costs, which we estimate at approximately $457,000 including costs to closing and post-closing reporting costs, or if compensation became payable before we raise capital, our existing cash would not be sufficient through that date, and we would need to reduce discretionary expenditures or obtain additional financing sooner than we expect. We nevertheless expect to require additional capital to complete the potential acquisition and to execute our business strategy at the scale we contemplate.

 

 

 

 28 

 

Material Commitments

 

As of September 30, 2026, we had no debt obligations, no capital commitments and no material contractual commitments other than (i) the at-will offer letters described above, under which salaries at an aggregate annual rate of $900,000 beginning the later of January 1, 2027 and the Company’s completion of additional fundraising, as deferred by the employees on November 15, 2026, (ii) our Advisory Agreement, which contains customary indemnification provisions, and (iii) our Investor Relations Agreement, under which we pay $10,000 per month through its initial term ending in January 2027, after which it renews automatically for six-month terms unless either party gives notice, payments held as of October 1, 2026 until uplisting. On November 2, 2026, we entered into a Tokenization Agreement with Securitize Transfer Agent, LLC, under which we will pay a $75,000 set-up fee, token issuance and monthly servicing fees, as described in Note 16 to the condensed financial statements. We have also entered into a non-binding letter of intent for a potential business acquisition, and engagement letters with legal and accounting advisors for that transaction; $231,542 of costs incurred under those engagements was included in accounts payable as of September 30, 2026. We were not a party to any material pending legal proceeding.

 

Purchase of Significant Equipment

 

We do not intend to purchase any significant equipment during the next twelve months.

 

Off-Balance Sheet Arrangements

 

As of September 30, 2026, we did not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

 

Known Trends and Uncertainties

 

·Our reported results will fluctuate with the market price of Omnitek’s common stock, because the Omnitek instruments are remeasured at fair value through earnings each quarter. A decline in that price would result in unrealized losses that could exceed the gains recognized in the current quarter.
   
·Most of the consideration from our first engagement was paid in securities. As of September 30, 2026, investment securities, consisting of the Omnitek instruments and our interest in Rift, represented approximately 91% of our total assets excluding cash, which exceeds the 40% threshold in Section 3(a)(1)(C) of the Investment Company Act of 1940. If a significant portion of our assets continues to consist of investment securities, we could be deemed an investment company under that Act unless an exclusion or exemption is available.
   
·We are pursuing a potential business acquisition under a non-binding letter of intent. We expect to continue to incur significant costs until it is completed or abandoned, and completing it will require financing that we have not yet obtained. If it is not completed, recovery of our costs will depend on the counterparty’s reimbursement.
   
·The deferred offering costs of $150,000 will be charged to expense if the related offering is abandoned or postponed for more than 90 days.
   
·

Salaries of approximately $900,000 per year will begin the later of January 1, 2027 and the Company’s completion of additional fundraising, which will reduce the net proceeds available to fund our strategy.

 

 

 

 29 

 

Critical Accounting Policies and Estimates

 

Our accounting and reporting policies comply with U.S. GAAP. The preparation of financial statements in compliance with U.S. GAAP requires us to make estimates and assumptions that could materially affect amounts reported in our financial statements. Critical accounting estimates are those that we believe are the most important to the portrayal of our financial condition and results of operations and that require us to make estimates that are difficult, subjective or complex. Our critical accounting estimates are described in our 2026 Form 10-K. During the quarter ended September 30, 2026, the following estimates became critical as a result of new transactions. We are generally unable to validate these estimates against independent third-party sources.

 

Revenue from noncash consideration

 

We measure noncash consideration received for advisory services, including warrants and options to acquire a client’s equity securities, at fair value at contract inception. Of our $681,290 of revenue for the quarter, $381,290 was noncash consideration in the form of the Omnitek fee warrants. Determining the amount of revenue required us to estimate the fair value of instruments that are not traded and to determine which of the instruments we received were consideration for our services. We recognized the warrants we purchased in Omnitek’s private placement at their $550,000 purchase price at initial recognition. Changes in the fair value of noncash consideration after contract inception are recognized in other income (expense), not revenue.

 

Fair value of investments

 

We measure the Omnitek warrants and option at fair value each reporting date using a Black-Scholes option-pricing model with Level 3 inputs, principally expected volatility and a discount for lack of marketability of 20.2% to 26.1% that reflects the restrictions on resale of the underlying shares under Rule 144. The measurements determined both the noncash revenue recognized at contract inception and the $1,614,095 unrealized gain recognized as of September 30, 2026. A 10% increase or decrease in the Omnitek stock price as of September 30, 2026 would have increased or decreased the fair value of these instruments by approximately $264,000. Because the warrants are deep in the money, changes in expected volatility have a much smaller effect. A 5-percentage-point change in the discount for lack of marketability would have changed their fair value by approximately $166,000.

 

The Black-Scholes model assumes continuous trading and a lognormal distribution of returns, which may not describe a stock that trades as infrequently as Omnitek’s, and both our September 29, 2026 initial measurements and our September 30, 2026 measurement rely on a closing price set on the day Omnitek announced the transactions. We therefore considered alternative inputs and approaches. Using Omnitek’s $0.025 volume-weighted average price on September 30, 2026 instead of its $0.0299 closing price would have reduced the fair value of the warrants by approximately $417,000. Using an expected term of one year, reflecting our intention to exercise within twelve months, instead of the contractual term would have reduced it by approximately $260,000; we used the contractual term because fair value reflects the assumptions of market participants rather than our own plans. We did not use the $0.002 per share implied by the price of Omnitek’s Series A preferred stock issued in the transactions, because that negotiated price for a newly designed preferred security issued to Omnitek’s incoming control party is not a quoted price for its common stock; at that price, Warrant 2026-01 would have been valued at approximately $121,000 at initial recognition, less than the $550,000 we paid. The warrants would generate cash only upon exercise and sale of the underlying shares, which will depend on the trading volume and price of Omnitek’s common stock and on the 4.99% beneficial ownership limitation in the warrants.

 

Advisory warrants

 

We estimated the grant-date fair value of the 14,000,000 warrants issued to an advisor and its designees at $1,802,084 ($0.1287 per warrant), using a Black-Scholes option-pricing model with a share price equal to the 30-day volume-weighted average price of our common stock reduced by a 50% discount for lack of marketability. We also concluded that the warrants were issued solely as consideration under our Advisory Agreement and are not costs of an offering, so the $1,662,084 excess of fair value over the cash received was expensed as professional fees. We measured the 250,000 shares of common stock to be issued to investor relations consultant at $35,598 ($0.1424 per share).

 

 

 

 30 

 

Valuation of our equity method investment

 

Rift is a private entity that holds the intellectual property rights to Rythe technology and has generated no revenue since its formation. Determining the carrying amount of our investment requires us to estimate our share of Rift’s results and to assess whether any decline in value is other than temporary, based on information obtained from an investee we do not control. The carrying amount was $39,800 as of September 30, 2026.

 

Income taxes

 

Our estimated annual effective tax rate depends on our forecast of fiscal 2027 income, the outcome of our Section 382 analysis, the effect of any cancellation of indebtedness income on our tax attributes, and our assessment of the realizability of deferred tax assets, including whether taxable temporary differences arising from unrealized gains and noncash consideration can be offset by existing deferred tax assets.

 

Recently Issued Accounting Pronouncements

 

See Note 2, Summary of significant accounting policies, to the condensed financial statements for a discussion of recently issued accounting pronouncements.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

Not applicable. As a smaller reporting company, we are not required to provide the information required by this Item.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.

 

Our management, consisting of David Wachsman, President (principal executive officer), and Q. Byron Hamlett, Chief Financial Officer (principal financial and accounting officer), evaluated the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, as of September 30, 2026. Based on that evaluation, our management concluded that, as of September 30, 2026, our disclosure controls and procedures were not effective in recording, processing, summarizing and reporting on a timely basis information required to be disclosed in the reports that we file or submit under the Exchange Act, and were not effective in assuring that information required to be disclosed in those reports is accumulated and communicated to management to allow timely decisions regarding required disclosure. This conclusion is due to the material weaknesses in our internal control over financial reporting described in Item 9A of our 2026 Form 10-K, which had not been remediated as of September 30, 2026: (i) only two officers handling all financial transactions; (ii) a lack of appropriate operational controls and of consistency in providing our accounting personnel with financial information; (iii) incomplete financial statements on a daily basis and resulting errors in our underlying accounting system; (iv) a lack of proper documentation of our assessment and evaluation; and (v) limited segregation of duties because of our limited management structure.

 

 

 

 31 

 

The volume and complexity of the transactions we entered into during the quarter — including noncash consideration received in the form of warrants and options, the issuance of equity-classified warrants for services, and related-party transactions — increased the risk associated with these material weaknesses.

 

Notwithstanding these material weaknesses, management believes that the condensed financial statements included in this Quarterly Report on Form 10-Q fairly present, in all material respects, our financial position, results of operations and cash flows for the periods presented in conformity with U.S. GAAP.

 

Remediation Plan

 

To respond to these material weaknesses, we have devoted, and plan to continue to devote, significant effort and resources to the remediation and improvement of our internal control over financial reporting. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will have the intended effects or that additional material weaknesses will not arise in the future.

 

Inherent Limitations on Effectiveness of Controls

 

Because of its inherent limitations, which include a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures, internal control over financial reporting may not prevent or detect misstatements, whether unintentional errors or fraud. Therefore, even those systems determined to be effective can provide only reasonable assurance of achieving their control objectives.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting during the quarter ended September 30, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 

 

 

 

 

 

 

 

 

 

 32 

 

PART II—OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

From time to time, we may be named in claims arising in the ordinary course of business. Currently, we are not aware of any legal proceedings contemplated by any governmental authority or any other party involving us or our properties. As of the date of this Quarterly Report on Form 10-Q, no director, officer, or affiliate is (i) a party adverse to us in any legal proceeding, or (ii) has an adverse interest to us in any legal proceedings. We are not aware of any other legal proceedings pending or that have been threatened against us or our property that, in the opinion of management, could reasonably be expected to have a material adverse effect on our business and financial condition.

 

Item 1A. Risk Factors.

 

Careful consideration should be given to the following risk factors, together with all other information set forth in this Quarterly Report on Form 10-Q, including our condensed financial statements and related notes, and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and in other documents that we file with the SEC, in evaluating Hawkeye Digital, Inc. (the “Company”, “we”, or “our”) and our business, before investing in our common stock. Investing in our common stock involves a high degree of risk. If any of the following risks and uncertainties actually occur, our business, prospects, financial condition and results of operations could be materially and adversely affected. The market price of our common stock could decline if one or more of these risks or uncertainties were to occur, which may cause you to lose all or part of the money you paid to buy our common stock. The risk factors described below disclose both material and other risks and are not intended to be exhaustive and are not the only risks facing us. New risk factors can emerge from time to time, and it is not possible to predict the impact that any factor or combination of factors may have on our business, prospects, financial condition and results of operations. Certain statements below are forward-looking statements. See “Special Note Regarding Forward-Looking Statements” in this Quarterly Report on Form 10-Q.

 

The risk factors below update and supplements the risk factors disclosed in Part I, Item 1A of our 2026 Form 10-K. Risk factors that are new or have been materially updated since the 2026 Annual Report on Form 10-K include those relating to our concentration in Omnitek securities, the receipt of securities as fees, our pursuit of a potential business acquisition, our salary commitments, significant accounting judgments, and our status under the Investment Company Act of 1940.

 

Risks Related to Our Business

 

A significant portion of our assets consists of warrants and an option to acquire the securities of a single, thinly traded issuer, and the value of those instruments may decline significantly or may not be realizable.

 

As of September 30, 2026, we held warrants and an option to acquire Omnitek common stock with an estimated fair value of $2,545,385, representing approximately 63% of our total assets. Omnitek’s common stock is quoted on the OTC market and is thinly traded. The instruments are not traded on any market, may be subject to contractual and securities-law transfer restrictions, and their fair value is estimated using a valuation model with significant unobservable inputs, including expected volatility. Because we remeasure these instruments at fair value through earnings each quarter, a decline in the market price of Omnitek’s common stock, or a change in our valuation inputs, would result in unrealized losses that could be significant relative to our results of operations. We recognized an unrealized gain of $1,614,095 on these instruments in the quarter ended September 30, 2026, without which our net loss for the quarter would have been substantially larger, and that gain may reverse.

 

Even if the instruments retain their estimated value, we may be unable to convert them into cash. Exercising the warrants or option may require us to pay the exercise price in cash, and any sale of the underlying shares would depend on the limited trading volume in Omnitek’s common stock and on the availability of an exemption from registration. A sale of a significant number of Omnitek shares could depress the market price of those shares. Accordingly, the carrying value of these instruments should not be viewed as a source of near-term liquidity.

 

 

 

 33 

 

We have accepted, and may continue to accept, securities of our clients as payment for our services, which exposes us to market, liquidity and regulatory risks.

 

Most of the consideration for our first advisory engagement was paid in securities of the client rather than in cash, and we expect that future engagements with early-stage and growth companies may also be paid, in whole or in part, in equity securities, warrants or other instruments. Securities received as fees may be illiquid, may decline in value before we are able to sell them, and expose us to the business and market risks of our clients. Receiving transaction-related compensation in securities may also be a factor in determining whether particular activities require broker-dealer registration, and accumulating investment securities may affect our status under the Investment Company Act of 1940, as described below. In addition, measuring securities received as fees requires significant judgment, and changes in their value will cause our reported results to fluctuate.

 

Our business depends on a small number of individuals whose services are provided under at-will arrangements.

 

Our strategy depends on the reputations, relationships and experience of our executive officers and directors. Effective September 1, 2026, our President and Chief Financial Officer became employees under at-will offer letters that may be terminated by either party at any time, and their salaries begin the later of January 1, 2027 and the Company’s completion of additional fundraising. We do not have non-competition agreements with our executive officers and do not maintain key-person life insurance. The loss of any of these individuals, or a change in the arrangements under which they provide services, would materially impair our ability to source and execute transactions.

 

We are pursuing a potential business acquisition that we may not complete, and we will incur significant costs whether or not it is completed.

 

We have entered into a non-binding letter of intent for a potential business acquisition. During the quarter ended September 30, 2026, we incurred $394,193 of legal, accounting, audit, quality-of-earnings and other costs in connection with the potential acquisition, and we expect to continue to incur significant costs until it is completed or abandoned. Completion is subject to, among other things, negotiation and execution of definitive agreements, satisfactory completion of due diligence, approval by our Board of Directors and our ability to obtain the financing necessary to complete it. There can be no assurance that we will complete the acquisition on acceptable terms or at all, or that any acquired business will perform as expected. Although the counterparty has agreed to reimburse transaction costs we have incurred if the acquisition is not completed, we may not recover those costs in full or on a timely basis, and we may be required to pay them before any reimbursement is received.

 

Salaries will increase our cash requirements and reduce the resources available to fund our strategy.

 

Under at-will offer letters with four employees effective September 1, 2026, salaries at an aggregate annual rate of $900,000 were to begin, and no compensation was accrued as of September 30, 2026. On November 15, 2026, the employees agreed to our deferral of the start of their compensation until the later of January 1, 2027 and the Company’s completion of additional fundraising. Once salaries begin, they will cost approximately $245,000 per quarter, including payroll taxes, at current staffing, which will reduce the resources available to execute our strategy. Employee medical coverage will begin when salaries begin.

 

Our financial statements reflect significant accounting judgments regarding complex transactions, and changes in those judgments could materially affect our reported results.

 

During the quarter ended September 30, 2026, we entered into transactions that required significant accounting judgments, including (i) the measurement of noncash consideration received for advisory services and the determination that the excess of the fair value of warrants we purchased over their purchase price, and the option, were not consideration for our services and were recognized in unrealized gain on investments, (ii) the measurement of the Omnitek warrants and option using Level 3 inputs, (iii) the measurement of the grant-date fair value of the advisory warrants, including the discount for lack of marketability, and the determination that the $1,662,084 excess over the cash received should be expensed as a cost of the Advisory Agreement rather than deferred as an offering cost, and (iv) the estimation of our annual effective tax rate in light of our Section 382 limitation and delinquent tax returns. If these judgments are changed as a result of further analysis, the review of our independent registered public accounting firm, or comments from the SEC staff, we could be required to revise our financial statements, and the effect could be material. For example, each 10-percentage-point change in the discount for lack of marketability applied to the advisory warrants would have changed our net loss for the quarter by approximately $385,000.

 

 

 

 34 

 

You will be unable to ascertain the merits or risks of any particular future acquisition.

 

Although we intend to focus on conducting private equity business and conducting merchant banking services in digital assets and other frontier verticals in finance and technology, our efforts to identify potential strategic partners will not necessarily be limited to a particular industry, sector or geographic region. To the extent we complete future acquisitions, we may be affected by numerous risks inherent in the business operations with which we combine. For example, if we acquire or make an investment in a financially unstable business or an entity lacking an established record of sales or earnings, we may be affected by the risks inherent in the business and operations of a financially unstable or a development stage entity. There are no assurances that any target business with which we consummate an acquisition will perform as anticipated. Although our officers and directors will endeavor to evaluate the risks inherent in a particular business, we cannot assure you that we will properly ascertain or assess all of the significant risk factors or that we will have adequate time to complete due diligence. Furthermore, some of these risks may be outside of our control and leave us with no ability to control or reduce the chances that those risks will adversely impact a business.

 

If we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements and our activities may be restricted, which may make it difficult for us to complete our future acquisitions.

 

If we are deemed to be an investment company under the Investment Company Act, we may have to change our operations, wind down our operations, or register as an investment company under the Investment Company Act. Our activities may be restricted, including:

 

·restrictions on the nature of our investments; and
   
·restrictions on the issuance of securities, each of which may make it difficult for us to complete future acquisitions.

 

In addition, we may have imposed upon us burdensome requirements, including:

 

·registration as an investment company;
   
·adoption of a specific form of corporate structure; and
   
·reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations.

 

In order not to be regulated as an investment company under the Investment Company Act, unless we can qualify for an exclusion, we must ensure that we are engaged primarily in a business other than investing, reinvesting or trading in securities and that our activities do not include investing, reinvesting, owning, holding or trading “investment securities” constituting more than 40% of our total assets (exclusive of U.S. government securities and cash items) on an unconsolidated basis.

 

As of September 30, 2026, investment securities, consisting principally of the Omnitek warrants and option received as advisory fees and purchased in a private placement, together with our interest in Rift, represented approximately 91% of our total assets exclusive of cash items. If we continue to receive fees in the form of securities or make additional investments, we may be unable to satisfy the 40% test and would need to rely on an exclusion or exemption, such as the exclusion for companies primarily engaged in a business other than investing in securities. If we were required to register as an investment company, we would be subject to the restrictions and requirements described above, which would be inconsistent with our strategy.

 

 

 

 35 

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

Recent Sales of Unregistered Securities

 

On July 20, 2026, in connection with an advisory agreement with an investment banking firm, we sold warrants to purchase an aggregate of 14,000,000 shares of common stock to that firm and fifteen of its designees at a purchase price of $0.01 per warrant, for aggregate proceeds of $140,000. The warrants have an exercise price of $0.01 per share, permit cashless exercise and expire on December 31, 2026. The sale was previously reported in our Current Report on Form 8-K filed on July 22, 2026, as amended on July 23, 2026. The warrants were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”). As described in our 2026 Form 10-K, we are presently not able to rely on the exemption from registration provided under Rule 506 of Regulation D. We used the proceeds for general corporate purposes.

 

On July 14, 2026, we agreed to issue 250,000 shares of restricted common stock to investor relations consultant as partial compensation for investor relations services under an Investor Relations Agreement. The shares had a grant-date fair value of $35,598 and had not been issued as of the date of this report. The shares will be issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act.

 

Issuer Purchases of Equity Securities

 

None.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

Rule 10b5-1 Trading Arrangements

 

During the quarter ended September 30, 2026, none of our directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Item 408 of Regulation S-K.

 

Cybersecurity

 

There have been no material changes to our cybersecurity risk management, strategy or governance from those described in Part I, Item 1C of our 2026 Form 10-K. During the quarter ended September 30, 2026, we did not identify any cybersecurity incident that has materially affected, or is reasonably likely to materially affect, us, including our business strategy, results of operations or financial condition.

 

Amendment of Compensatory Arrangements of Certain Officers

 

On November 15, 2026, the Company entered into amendments to the at-will employment offer letters dated September 1, 2026 with David Wachsman, its President and principal executive officer, and Q. Byron Hamlett, its Vice President and Chief Financial Officer and principal financial officer. Under the original letters, Mr. Wachsman’s annual base salary of $360,000 and Mr. Hamlett’s annual base salary of $270,000 were to begin upon the Company’s completion of additional fundraising, and Company-paid medical coverage, is deferred until the later of January 1, 2027 and the Company’s completion of additional fundraising. The amendments did not change either officer’s annual base salary or the at-will nature of employment. No compensation was earned or accrued under the offer letters as of September 30, 2026. The Company’s two other employees, including Derek Wachsman, Vice President and the brother of Mr. Wachsman, agreed to the same deferral on the same date. The foregoing description is qualified in its entirety by reference to the amended offer letters, which are filed as Exhibits 10.1 and 10.2 to this Quarterly Report on Form 10-Q and are incorporated herein by reference.

 

 

 

 36 

 

Item 6. Exhibits.

 

Exhibit Description
10.1#* Amended Employment Offer Letter, dated November 15, 2026, between the Company and David Wachsman
10.2#* Amended Employment Offer Letter, dated November 15, 2026, between the Company and Quinton Byron Hamlett
31.1* Certification of Principal Executive Officer pursuant to Rule 13a-14(a)/15d-14(a)
31.2* Certification of Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14(a)
32.1** Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350
32.2** Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350
101.INS Inline XBRL Instance Document (embedded within the Inline XBRL document)
101.SCH/CAL/DEF/LAB/PRE Inline XBRL Taxonomy Extension Schema, Calculation, Definition, Label and Presentation Linkbase Documents
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

* Filed herewith. ** Furnished herewith. # Management contract or compensatory plan or arrangement.

 

 

 

 37 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  HAWKEYE DIGITAL, INC.
   
Date: November 16, 2026 By: /s/ David Wachsman
  David Wachsman, President (Principal Executive Officer)
   
   
   
Date: November 16, 2026 By: /s/ Q. Byron Hamlett
  Q. Byron Hamlett, Chief Financial Officer (Principal Financial and Accounting Officer)

 

 

 

 

 

 

 

 

 

 

 38 

 

Keep reading